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During early development, hematopoietic stem cells (HSCs) have been 
identified in the yolk sac, aorta-gonado-mesonephros (AGM) region, placenta 
and fetal liver.  In an effort to understand how the embryonic 
microenvironments influence HSC proliferation and its maintenance, we 
performed a comparative qPCR analysis at various developmental time points 
for the yolk sac, AGM, placenta and fetal liver.  We investigated the 
expression pattern of angiopoietin-like protein 3 (Angptl3), insulin-like growth 
factor 2 (IGF2), kit ligand (Kitl)/stem cell factor (SCF) and thrombopoietin 
(TPO) in these tissues and whether these factors could be defining markers for 
a HSC-supporting stromal cell. Previous studies have shown that a 
combination of these growth factors supports proliferation of HSCs in a 
serum-free ex vivo culture system. Intriguingly, we also found that the yolk sac 
expresses high levels of these known HSC supportive growth factors. Thus we 
hypothesize that potential HSCs-supportive stromal cells might exist in the 
yolk sac. We identified a population of cells from day E10.5 yolk sac 
expressing these HSC-supportive growth factors. These cells are large in size, 
have high granularity and express intermediate levels of Delta-like-1 (Dlk-1), 
a marker recently reported to enrich the fetal liver HSC-supporting stromal 
cells.  We determined this population of cells is of the endoderm lineage, 
evident by their specific expression of endoderm markers. To examine the 
function of these yolk sac endoderm cells, we co-cultured these cells with 
bone marrow cells in vitro, and the results revealed that these endoderm cells 
greatly support proliferation of bone marrow derived hematopoietic progenitor 
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cells. Moreover, cell-cell contact is needed to support proliferation 
/maintenance of the enriched HSC/progenitor population, i.e. lineage-Sca-1+c-
kit+   cells. However, HSCs are not maintained in co-culture with yolk sac 
endoderm cells. In addition, we also performed genome-wide analysis on yolk 
sac cells to uncover more essential growth factors for HSC/progenitor 
expansion and maintenance. A novel growth factor, midkine, for supporting 
HSCs during ex vivo culture was identified. Through long-term transplantation 
assay, we demonstrated that the addition of midkine at an intermediate 
concentration will facilitate maintenance of HSCs up to 4 days. Our findings 
suggest that primary extraembryonic endoderm cells may serve as 
hematopoietic progenitor supportive stromal cells. Midkine is a novel growth 
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1.1 HSC fate regulation depends on its niche 
The definition of a hematopoietic stem cell (HSC) is generally accepted as a 
single cell that can self-renew throughout lifetime and also differentiate into 
all cell types in the blood system (Iwasaki and Akashi, 2007; Cumano and 
Godin, 2007). HSCs niches are defined as the in vivo microenvironments that 
host HSCs and regulate HSC behaviors (Hackney et al., 2002b; Zhang et al., 
2003b; Calvi et al., 2003b; Taichman, 2005; Suda et al., 2005; Kopp et al., 
2005; Scadden, 2006). These niches consist of stromal cells, which are the cell 
compartments of niches, and the extracellular matrix (ECM). HSC niches are 
crucial for determination of the HSC fates, including quiescence, self-renewal, 
apoptosis, differentiation, and migration (Zhang et al., 2003b; Calvi et al., 
2003b). In vivo, the stromal cells of a niche maintain the stemness of HSCs, so 
that the HSCs mainly stay quiescent in vivo (Passegué et al., 2005). Niche 
cells regulate HSCs either through direct cell-cell contact or via specific 
signaling pathways. Inhibition of these regulation mechanisms can lead to 
migration of HSCs from their original location as well as cell fate changes 
thereafter, e.g. cell division, differentiation and apoptosis (Scadden, 2006).  
Experimental conditions during the in vitro culture of HSCs, which are 
removed from their physiological microenvironment, often cause apoptosis or 
differentiation rather than HSC maintenance or amplification (Miller and 
Eaves, 1997). Taken together, better understanding of the mechanism by 
which HSCs are regulated by their niches will facilitate development of state 
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of art biomedical engineering technology for treatment of various types of 
blood diseases.  
1.2 Comparison between fetal and adult HSCs  
HSCs of fetal and adult origins differ from each other significantly, and 
further understanding of the underlying differences may help to elucidate 
essential mechanisms regulating HSCs. Basically, fetal HSCs are more 
predisposed to undergo dramatic expansion in order to meet the needs for 
supporting growth and maturation of the embryo (Lessard et al., 2004) ,  while 
adult bone marrow HSCs mainly remain in a quiescent state.  
Besides the difference in the cell cycle status, another major difference lies in 
the surface characteristics of these two types of HSCs. In mice, down-
regulation of CD34 expression by the quiescent bone marrow HSCs was 
documented (Ogawa et al., 2001). Interestingly, a reverse up-regulation of 
CD34 expression was observed once the HSCs are mobilized to leave their 
original niche through 5-fluorouracil (5-FU) administration (Ogawa, 2002). In 
addition, unlike adult HSCs, fetal HSCs selectively express some lineages 
markers, e.g. Mac-1 and AA4.1 (Jordan et al., 1995; Jordan et al., 1990; 
Morrison et al., 1995; Rebel et al., 1996b). Yet, whether the differential 
surface marker expression between the two HSC types has a direct 
relationship with their unique functional characteristics still remains unknown.  
1.3 Sites of hematopoiesis during early embryogenesis 
Throughout adulthood, the bone marrow serves as the niche for maintenance 
of the rare number of HSCs. However, the original pool of HSCs is formed 
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through a complex developmental process, in which multiple anatomical sites 
are involved including the yolk sac, AGM, fetal liver and placenta (Figure 1-1) 
(Mikkola et al., 2005a). Prior to the establishment of the hematopoietic system 
to sustain blood production throughout adulthood, differentiated blood cells 
are also needed by the developing embryos. Thus, multiple organs develop to 
support hematopoiesis, and this mechanism is conserved between mice and 
human, and even among other species, e.g. zebrafish (Ciau-Uitz et al., 2000; 








Figure 1-1.  Hematopoietic organs in a mouse embryo at E11.5.   
The hematopoietic organs of a mouse embryo at E11.5 are shown. The four 
organs are: yolk sac (yellow); AGM (green); fetal liver (red); placenta (blue). 




Figure 1-2.  A model of fetal HSC development showing the major 
anatomical sites involved.   
The primitive streak (a source of mesoderm that gives rise to the 
hemangioblast, i.e., the common precursor for hematopoietic and endothelial 
cells), the yolk sac (a site of embryonic red blood cell production and 
formation of a large number of definitive hematopoietic progenitors, P), the 
AGM (a source of rare HSCs), the placenta (a putative novel site for HSC 
production and supportive niche for HSC maturation/expansion), the fetal liver 
(the main site for HSC expansion and lineage differentiation during fetal life), 
and the bone marrow (the final destination of adult definitive HSCs). Arrows 
indicate possible routes of hematopoietic cell trafficking. The gray arrows 
represent migration of HSC precursors through embryonic tissues before the 
establishment of circulation, whereas the black arrows represent hypothesized 
HSC circulation through major vascular connections between the organs. The 
gray arrow with a dotted line represents possible extravascular migration 
between the AGM and the fetal liver, although such a pathway has been 




1.3.1 The yolk sac is a site for production of the first blood cells  
The yolk sac has a bilayer structure consisting of cells derived from both 
mesoderm and endoderm germ layers (Saitoh and Katoh, 2002). The yolk sac 
visceral endoderm develops from extraembryonic tissues prior to gastrulation. 
The yolk sac visceral endoderm cells have been known to possess similar 
functions as the fetal livers in terms of serum protein production and 
transportation of maternal nutrients (Jollie, 1990). The mesoderm layer of the 
yolk sac has been recognized as a site where the first blood cells originated. It 
is generally believed that the hemangioblast (Fehling et al., 2003), a subset of 
the mesoderm cells, give rise to both hematopoietic and vascular endothelial 
cells (Sabin, 1917).  This long-standing hypothesis is supported by both in 
vitro EB differentiation assays and in vivo mice models. In vitro, ES-derived 
blast colony forming cells are able to differentiate into hematopoietic, 
endothelial and vascular smooth muscle cells (Choi et al., 1998; Kennedy et 
al., 1997). In vivo,  hemangioblasts do exist in the mouse embryo during 
gastrulation process (Huber et al., 2004). The hemangioblast-derived 
hematopoietic and endothelial cells, together with the adjacent visceral 
endoderm constitute the blood island (Palis and Yoder, 2001). 
Hematopoiesis within the yolk sac takes place in a two-wave manner. During 
the first wave of primitive hematopoiesis, primitive erythroblasts originate 
from the blood islands at E7.5 and enter circulation at E8.5 (Hankenson et al., 
2006; Armstrong et al., 2002). These primitive erythroid cells have unique 
characteristics distinguishable from the definitive erythroid cells. They are 
large in size, remain nucleated and produce both embryonic and adult forms of 
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hemoglobins (Ferkowicz et al., 2003a; Palis et al., 1999a). The second wave 
of hematopoiesis, the definitive program, begins at approximately E8.25, 
when definitive myeloerythroid progenitors appear in the yolk sac (Cumano et 
al., 1996; Palis et al., 1999a). An expansion of definitive progenitors is 
observed between E8.25 and E10.5 in the yolk sac, indicating that the yolk sac 
niche might provide necessary signals for progenitor expansion during this 
period. Both primitive and definitive hematopoietic cells produced by the yolk 
sac fulfill the requirements of functional blood cells for survival and growth of 
the embryos (Streit et al., 1999) . 
On the other hand, there are controversial theories about whether HSCs are 
generated within the yolk sac. The main evidence against this hypothesis 
stems from the experiments showing that yolk sac explants are not able to 
reconstitute adult blood system (Cumano et al., 1996; Cumano et al., 2001; 
Medvinsky and Dzierzak, 1996). However, failure for the immature yolk sac 
progenitors to engraft the adult microenvironment might be the cause of this 
phenomenon. In contrary, lines of evidence supporting an alternative theory 
were also reported in recent years. Firstly, E12.5 yolk sac explant was shown 
to support HSC proliferation during culture (Kumaravelu et al., 2002). 
Secondly, E8.5 and E9.5 yolk sac cells were shown to be able to engraft 
newborn recipients (Yoder et al., 1997a; Yoder et al., 1997b). However, it was 
also suggested that the HSCs detected in the yolk sac may be of AGM origin, 
and they simply reach the yolk sac through circulation (de Bruijn et al., 2000). 
Latest data quantifying the absolute number of adult-repopulating HSCs 
within the yolk sac during embryonic development suggests that the yolk sac 
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might also serve as a microenvironment supporting expansion of HSCs during 
the period from E11 to E13 (Kumaravelu et al., 2002; Gekas et al., 2005; 





Figure 1-3.  Developmental Kinetics of HSCs and Clonogenic Progenitors.   
(A) Quantification of long-term repopulating units (RUs) in each 
hematopoietic organ. The numbers demonstrates the capability of each 
hematopoietic organ to reconstitute the peripheral blood of the recipient mice. 
(B) Quantification of total in vitro colony-forming progenitors (CFU-Cs) 






Figure 1-4.  Kinetic quantification of primitive and definitive colony-
forming progenitors within various hematopoietic sites during mouse 
embryogenesis.   
The graphs shows the numbers of primitive erythroid (EryP-CFC), definitive 
erythroid (BFU-E and CFU-E), macrophage (Mac-CFC) and mast cell (Mast-
CFC) progenitors (mean ± s.e.m.) within different hematopoietic organs of 










1.3.2 De novo generation of the adult-repopulating HSCs within the 
AGM region 
Study of the chick-quail chimera first brought up the notion that HSCs are 
generated within the embryo proper (Lassila et al., 1978; Martin et al., 1979). 
In the following years,  similar conclusions were also drawn for several other 
species including mice and human (Jaffredo et al., 2005). In mice, as early as 
E8.5, explant culture of the entire para-aortic splanchnopleurae (pSP) region 
give rise to recipient-repopulating HSCs (Cumano et al., 2001). Since it is at 
the stage before circulation is established, it rules out the possibility that the 
HSCs migrated from other hematopoietic sites within the embryo. The pSP 
subsequently develops into the aorta-gonadmesonephros region (AGM), in 
which adult-repopulating HSCs can be isolated at around E10.5 (Cumano et 
al., 1996; Godin and Cumano, 2002; Jaffredo et al., 2005; Medvinsky and 
Dzierzak, 1996; Muller et al., 1994), though the number of HSCs are very 
limited.  
Different approaches were taken to confine the location where HSCs reside 
within the AGM, and it is concluded that the aorta, but not the urogenital 
region contains most HSCs (Godin et al., 1999). Advanced confocal imaging 
technology provides a tool to directly visualize and locate emerging HSCs 
within the AGM. More recently, it is found that HSCs, marked by expression 
of CD31 and CD41, reside in both intra-aortic clusters and the endothelium 
layer (Bertrand et al., 2005). Later, more evidence support the hypothesis that 
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AGM HSCs emerge through an intermediate endothelial cell named 
hemogenic endothelium (Dieterlen-Lievre and Jaffredo, 2009). 
1.3.3 Fetal liver is a place for dramatic expansion of HSC and lineage 
differentiation  
It is generally accepted that the fetal liver is not responsible for de novo 
generation of HSCs; rather its main function is to support expansion as well as 
differentiation of HSCs and hematopoietic progenitors. During early 
development, hematopoietic activity can be detected in the fetal liver from 
E10 onwards. The quantification of the absolute number of both HSCs and 
progenitors within different hematopoietic tissues around E10 (Figure 1-3) 
suggests that colonization of AGM-derived HSCs might not be sufficient to 
explain the sudden surge in HSCs detected in the fetal liver (Godin et al., 
1999). Another explanation would be that progenitors initially seed the fetal 
liver rudiment originated from the yolk sac, in which numerous definitive 
progenitors arise. Thus, upon seeding the fetal liver, yolk sac-derived 
progenitors rapidly differentiate, which, at least partially, contribute to the 
high hematopoietic activity observed in the fetal liver.   
The first functional HSC can be found in the fetal liver at E11.5, and these 
HSCs undergo expansion as well as differentiation from E12.5. Fetal HSCs 
acquire the characteristic surface markers for adult HSCs at around E15, 
which is also the stage when the number of HSCs reaches the maximum (Ema 
and Nakauchi, 2000; Morrison et al., 1995). In addition, differentiation of 
lineage-specific progenitor cells also takes place in the fetal liver to give rise 
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to erythrocytes, myeloid cells, and lymphocytes (Godin and Cumano, 2002; 
Igarashi et al., 2001).  
In order meet the different requirements to support either HSC expansion or 
lineage differentiation, the fetal liver develops a complex microenvironment 
and modifies it subsequently throughout the development. The fact that 
cycling fetal liver HSCs outcompete quiescent adult bone marrow HSCs 
during engraftment into transplanted recipients (Harrison et al., 1997; 
Morrison et al., 1995; Rebel et al., 1996a) raises the hypothesis that fetal liver 
niches might provide signals that stimulate HSC self-renewal. Many attempts 
have been made trying to further dissect the key molecular and cellular 
components within the fetal liver. However, there is still a lack of direct 
evidence showing the physical interaction between the hematopoietic cells and 
the microenvironment within the fetal liver. Better defined markers 
characterizing the fetal liver stromal cells may provide a powerful tool to 
allow visualization of the hematopoietic niche structure. 
1.3.4 Placenta as a novel putative site for generation and expansion of 
HSCs  
The placenta has traditionally been known as a major organ responsible for the 
production of necessary hormones and growth factors that are important for 
embryo development as well as to the waste elimination and gas exchange of 
the embryo via the maternal blood supply (Taichman and Emerson, 1996; 
Taichman and Emerson, 1994).   Early studies hint the possible role that 
placenta may play during hematopoiesis (Li et al., 2003b; Ito et al., 2004; 
Heissig et al., 2002; Thomas et al., 2004), however, it is only recently that the 
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placenta has been well investigated and described as a major hematopoietic 
organ.  Starting from E8.5, the allantois develops to form the fetal placenta,  
followed by the establishment of the vasculature system which includes the 
umbilical artery connecting the AGM and the placenta (Mitjavila-Garcia et al., 
2002).  
As early as E9, definitive hematopoietic progenitors can be found in the 
placenta (Gardner et al., 1997), whereas adult repopulating HSCs become 
detectable in the placenta only after E10.5 (Rebel et al., 1996b; Hofmann et al., 
2004).  The notion that de novo generation of HSCs happens in the placenta is 
mainly supported by much evidence that HSCs appear in the placenta before 
circulation is establish in the embryo. Moreover, the allantoic mesoderm is 
proposed to be the original source of the placental HSCs. However, more 
evidence is needed to rule out the possibility that AGM-derived HSCs 
colonize the placenta through the umbilical vessels (Sadler, 2006), and 
undergo further maturation and expansion in the placenta.  
In addition, observations that rapid HSCs expansion take place in the placenta 
from E11.5 to E13.5 have made the placenta a novel HSC niche for  further 
investigation. Although a few signaling molecules related to HSCs have been 
found present in the placenta (Li et al., 2008a; Li et al., 2008b; Mao et al., 
2008; Hattori et al., 2002; Li et al., 2008c; Zhang and Lodish, 2004a), more 
work is still required to fully dissect the cellular composition of the placental 




1.3.5 Bone marrow provides a niche for maintaining homeostasis of 
HSCs throughout adulthood  
Return of HSCs to the inner surface of bone is mostly characterized through 
homing assays (Nilsson et al., 2001), however, the bone marrow niche 
remains elusive in terms of its  accurate location, its  cellular components, and 
the underlying signaling pathways of the bone marrow HSC 
microenvironment.   
The main function of the bone throughout adulthood is to provide structure 
and support movement of the body. In the animal model of mouse, the 
development of the skeletal system initiates as early as E12.5, when 
mesenchymal cells differentiate into chondrocytes and form the framework for 
the skeleton (Olsen et al., 2000).  Following this mesenchymal condensations 
process is another process called endochondral ossification, where osteoblasts 
replaced chondrocytes and generated calcified bone. Hematopoietic activity 
starts to be detectable in the skeleton system from the third week of gestation 
onwards, and both hematopoietic progenitors and stem cells reached the bone 
through the complex vascular system infiltrating the bones. At E15.5, 
hematopoietic progenitors can be found in the long bones.  HSCs are 
subsequently detectable after E17.5 (Christensen et al., 2004; Gekas et al., 
2005). In the adult bone marrow, hematopoietic cells are encased by the bone 
structure, which consists of bone cells, collagen, and mineral deposits, e.g. 
calcium and phosphate (Boskey and Posner, 1984; Meghji, 1992).  Soft bone 
marrow and blood vessels are the major components filling the bone cavity.  
Recently, our knowledge regarding the composition of bone marrow HSC 
niches has been significantly enhanced by great progress in the field. In 
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general, there are two types of niches within the bone marrow identified for 
supporting HSCs, and they are the osteoblastic niche and the vascular niche.  
The earliest observation of simultaneously increased osteoblast and HSC 
numbers in mice with reduced Bmpr1a (bone morphogenetic protein receptor 
1) signaling  led to the discovery of the osteoblastic niche as niche cells (Calvi 
et al., 2003a; Zhang et al., 2003a) This notion is further supported by the 
evidence that osteoblasts produce several growth factors supporting 
hematopoiesis (Taichman et al., 1996; Taichman et al., 2001). Moreover, in 
the mutated mice, which lack M-CSF, progenitors for both macrophages and 
osteoclasts were lost (Begg et al., 1993).  Both in vitro co-culture experiments 
(Taichman and Emerson, 1994; Taichman et al., 2000) and study of transgenic 
mouse models (Zhang et al., 2003a; Calvi et al., 2003a; Arai et al., 2004) 
revealed that ablation of osteoblasts results in loss of HSCs as well as 
hematopoietic cells, implying the function of osteoblastic niches for 
supporting HSCs.  A popular model that HSCs colonizing in adjacency with 
the endosteal bone surface undergo cell division to give rise to progenitors was 
supported by several lines of evidence (Nilsson et al., 2001; Gong, 1978; 
Heissig et al., 2002).  
On the other hand, both early stage and most recent HSC localization studies 
point out that hematopoietic progenitors (Li et al., 2004; Cardier and Barbera-
Guillem, 1997) and HSCs expressing SLAM markers (CD150+CD48–CD41–) 
(Kiel et al., 2005) were found in  contact with the sinusoidal endothelium in 
bone marrow, suggesting the existence of an alternative vascular niche for 
HSCs. Similar to the osteoblastic niche, disruption of the vascular niche in 
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vivo inhibits normal hematopoiesis (Avecilla et al., 2004).  In addition, the 
vascular niche also supports migration of HSCs during mobilization and 
homing processes (Lapidot et al., 2005; Cancelas and Williams, 2006). 
Moreover, vascular niches are also deemed as the place where large quantity 
of HSCs can be quickly restored when the bone marrow is suppressed (Kiel et 
al., 2005).  
Taken together, a model of bone marrow HSC niches incorporating the two 
alternative stromal cell types is proposed: The osteoblastic niche provides 
signals required to maintain HSCs in quiescent state, while the vascular niche 
mainly accelerates the process of hematopoiesis. HSCs can employ either 
niches depending on different physiological circumstances (Wagers, 2005). As 
HSCs localized in both bone marrow niches were found to be in the same cell 
cycle status, more work is needed to test the validity of the hypothetic model.   
1.4 Significance of HSC microenvironments 
A stem cell niche is defined as a specific location within which stem cells 
reside and undergo self-renewal as well as give rise to a number of progenies. 
The stem cell niche is constructed by surrounding cells that form a proper 
physiological microenvironment and provide necessary extrinsic signals for 
stem cells (Li and Xie, 2005; Spradling et al., 2001; Lin, 2002). In 1978, the 
concept of the HSC microenvironment, for the first time, was described as a 
limited physiological site where HSCs reside (Schofield, 1978). This proposed 
concept was later supported by a series of in vitro co-culture experiments 
(Dexter et al., 1977; Moore et al., 1997a; Rios and Williams, 1990; Roecklein 
and Torok-Storb, 1995; Sitnicka et al., 1996; Li et al., 2004). Fetal and adult 
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HSC microenvironments share a set of same signals; however, much evidence 
implies that they may also employ distinct regulatory mechanisms. Firstly, 
fetal and adult HSCs undergo different biological processes, with de novo 
generation and proliferation of HSCs taking place in the embryo while 
homeostasis being maintained within the adult bone marrow. Secondly, 
different sets of transcription factors are required at each stage during HSC 
development (Teitell and Mikkola, 2006). Thorough study of the biology of 
HSCs and their niches is required to better elucidate the underlying cellular 
and molecular mechanisms that govern the fates of HSCs.  Thirdly, even at the 
same anatomical site, significant changes take place when it shifts from the 
fetal program to the adult program. This is evident by the fact that although 
adult bone marrow stromal cells employ Sdf1 (stromal cell-derived factor 1), a 
ligand for chemokine (C-X-C motif) receptor 4 (Cxcr4), to direct proper 
colonization of HSCs, fetal bone marrow is unable to retain circulating HSCs 
during early developmental stages (Ara et al., 2003).  
Only recently, the necessity of niche study has been appreciated, and it is well 
understood that novel knowledge of the HSC regulatory program has great 
potential to be translated into clinical applications for both HSC culture and 
manipulation. In fact, great challenges remain to be overcome before the 
benefits from the niche study could be realized.  






1.5.1 Primary cells 
For years, many attempts have been carried out to identify and characterize 
stromal cells from different hematopoietic sites. Generally, these attempts can 
be broadly categorized into three major classes based on the cell types used i.e.  
primary cells, cultured cells and cell lines. Example of each approach will be 
given as below. 
For primary cells, YS endothelial cells were sorted by Li et al. from E9.5 
embryos, and they were shown to be capable of supporting BM-HSCs 
expansion (Li et al., 2003a). However, the limitation of this study is that 
following a specific lineage of cells excluded other possible cell types that 
might serve as important stromal cells. As for the cultured cells, FL cells were 
isolated from E14.5 embryo and then were put into culture for 2 days, during 
which the cells underwent a selection process based on their survival. The 
selected cells can expand AGM-derived HSCs (Takeuchi et al., 2002). Since 
the cells might have already changed their phenotypes during culture, they do 
not fully represent the corresponding stromal cells in vivo.   
Scientists in the Lodish laboratory have identified a CD3+ stromal cell 
population in E15 fetal liver (Zhang and Lodish, 2004a) shown to support a 
net expansion of HSC in an in vitro culture system supplemented with 
Kitl/SCF and TPO. Subsequently, IGF-2 and angiopoietin-like proteins 2 and 
3 (Angptl2 and Angptl3) were found to be specifically expressed in this CD3+ 
population  compared  to other proteins (Zhang et al., 2006a). Based on these 
findings, Lodish lab developed a serum-free culture system  containing low 
but saturated level of Kitl/SCF, TPO, Fibroblast Growth factor-1 (FGF-1), 
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IGF-2 and either Angptl2 or Angptl3, which supports  up to 30-fold expansion 
of HSC during the ex vivo culture. At the same time, insulin-like growth factor 
binding proteins (IGFBPs) were found to be HSCs supportive growth factors 
as well (Zhang et al., 2008a).  
Recent study in the Lodish laboratory has shown that Dlk-1 and Kitl/SCF 
might serve as more efficient surface markers to isolate the potential stromal 
cells from E14 FL. A population of Dlk-1+SCF+ cells from E14.5 mouse FL 
was shown to express high levels of the four growth factors contained in the 
serum-free culture system our laboratory developed that can expand HSC 
more than 30 fold ex vivo (Zhang and Lodish, 2005).  Since the four growth 
factors, Angptl3, IGF-2, TPO and Kitl/SCF, form a complete set of growth 
factors that facilitate ex vivo expansion of HSCs, the newly identified Dlk-
1+SCF+cells should be able to support HSC expansion without addition of 
other growth factors. Thus, Dlk-1+SCF+ cells are likely to represent the HSC 
supporting stromal cells in the E14.5 FL. 
The application of a novel combination of surface markers enables the 
purification of primary cells from the tissues without only focusing on a 
specific cell lineage. Based on the approach established in our laboratory, our 
study on the early stage stromal cells will reveal the biological mechanisms, 
by which HSCs are generated, maintained and expanded.  
1.5.2 Cell lines 
In addition, many stromal cell lines have been established from multiple 
hematopoietic sites (Oostendorp et al., 2002a; Kusadasi et al., 2002; Moore et 
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al., 1997a; Oostendorp et al., 2002b). For example, AGM-derived stromal 
cells lines proved to support HSC activity in culture (Kusadasi et al., 2002; 
Oostendorp et al., 2002a; Oostendorp et al., 2005). Moreover, stromal cell 
lines with differential capabilities to support HSCs were compared in terms of 
gene expression. However, whether the identified genes are important factors 
for HSC expansion still needs to be further investigated (Hackney et al., 
2002a). Among the hematopoiesis-supportive stromal cell lines reported, three 
stromal cell lines have been thoroughly studied. The three stromal cell lines 
include two AGM-derived cell lines, AM20.1B4 and UG26.1B6, as well as 
one fetal liver-derived cell line- EL08.1D2. These three cell lines have the 
ability to maintain adult HSCs, as well as to enhance hematopoietic 
differentiation of human ESCs (Ledran et al., 2008).   
However these cell lines underwent immortalization, hence, they are not 
exactly the same cells as they were in vivo, so that the true functions of the 
stromal cells might have not been revealed yet. 
1.6 Hematopoietic growth factors 
During the period from 1980s to early 2000s, great progress was made in 
discovering novel hematopoietic growth factors, which were also tested by 
scientists in terms of their ability to promote HSC amplification in vitro. For 
example, interleukin 3 (IL-3) and interleukin 6 (IL-6) act synergistically to 
stimulate self-renewal divisions of HSCs in cultures (Bodine et al., 1989).  
Later on, Kitl/SCF was found to increase the number of HSCs during in vitro 
culture, when combined with IL-3 and IL-6 (Bodine et al., 1992). Another 
analysis of the effects of sixteen  cytokines on human long-term culture-
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initiating cells (LTC-IC) revealed that fms-related tyrosine kinase 3 (FLT3) 
and thrombopoietin (TPO), as single factors, enhanced LTC-IC numbers 
during culture (Petzer et al., 1996). Moreover, addition of interleukin-11 (IL-
11) was also included in a culture media containing Kitl/SCF or FLT3 to 
expand bone marrow HSCs (Miller and Eaves, 1997). In addition, expression 
of delta-like/preadipocyte factor-1 on either fetal liver stromal cells line or 
hematopoietic cells promotes the maintenance and self-renewal of HSCs 
(Moore et al., 1997c; Li et al., 2005). Vascular endothelial growth factor 
(VEGF) was found to play an important role in HSCs survival. However, 
extracellular modulations of the VEGF pathway do not have the same effects 
as intracellular acting small-molecule, making it less likely to employ VEGF 
as a soluble factor in culture (Gerber et al., 2002). Fibroblast growth factor 1 
(FGF-1) supplemented serum-free medium was also reported to facilitate 
robust expansion of HSCs (de Haan et al., 2003). More recently, insulin-like 
growth factor 2 (IGF-2) was identified to support 2-fold ex vivo expansion of 
both fetal and adult HSCs (Zhang and Lodish, 2004b). However,  till early 
2000s, attempts to amplify HSCs using exhaustive combination of growth 
factors only yielded more than a fourfold increase of the stem cells (Bhatia et 
al., 1997; Glimm and Eaves, 1999), hence  new factors capable of improving 
the expansion efficiency have always been an interest for both academic 
researchers as well as the pharmaceutical industry.  
Most recently, a few novel growth factors have been reported to significantly 
enhance the efficiency of in vitro expansion of HSCs. First, several members 
of the angiopoietin-like protein family were found to be HSC-expansion 
factors, including angiopoiein-like 2 (Angptl2), angiopoiein-like 3 (Angptl3), 
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angiopoiein-like 5 (Angptl5) and angiopoiein-like 7 (Angptl7). In combination 
with saturating levels of other growth factors, Angptl2 or Angptl3 was able to 
stimulate expansion of long-term HSCs by 24- or 30-fold (Zhang et al., 
2006b). IGF-binding protein 2 (IGFBP2) was another novel growth factor 
identified to support an about 20-fold ex vivo expansion of human HSCs in a 
serum-free medium containing Kitl/SCF, TPO, FGF-1 and Angptl5 (Zhang et 
al., 2008b). A new regulator of both HSC expansion and regeneration, 
pleiotrophin (Ptn) was also found to have effects on human HSCs through 
activated phosphoinositide 3-kinase (PI3K) signaling pathway (Himburg et al., 
2010b). Besides growth factors, screening of small molecules revealed that 
prostaglandin (PG) E2 (PEG2) regulates HSC homeostasis as well as 
facilitates expansion of HSCs (North et al., 2007).  
Although various kinds of protocols using combination of growth factors have 
been developed for HSC expansion, so far, the current state-of-art techniques 
still have not met the requirements of clinical application in terms of 
efficiency, purity and potency. Thus, there is still a dire need for the 
identification of new factors and their signaling pathways for modulation of 
HSCs fates in vitro. 
1.7 Aim of the study 
Challenges remain to further dissect the hematopoietic niches in order to 
reveal specific cellular and molecular components important for control of 
HSC fates. Novel knowledge of key factors affecting HSC proliferation and 
differentiation might be translated into practical tools for culture or 
manipulation of HSCs. Thus the limitation associated with bone marrow/cord 
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blood transplantation, the insufficient number of HSCs within the donor cells, 
might be overcome in future.  Specifically, better understanding of the HSCs 
niches would enable us to more accurately mimic the in vivo 
microenvironment that is supportive for HSC expansion. Moreover, the 
resulting technology may even be utilized to direct differentiation of 
hematopoietic cells from embryonic stem cells.  
The long term goal of this study is to identify the stromal cells, in order to 
improve the efficiency of HSC expansion in vitro, and also to elucidate the 
mechanisms of how the HSC fate is regulated. In order to achieve these goals, 
relevant experiments were performed according to the specific aims as below:   
Aim 1. Isolate stromal cells from hematopoietic tissues in early stage 
mouse embryo. Test their ability to maintain and expand HSCs and 
hematopoietic progenitors in vivo and in vitro. 
a. To validate markers used for isolation of the stromal cells by 
examination of the expression level of key HSC-supportive growth 
factors in the sorted cells.  
b. To test the ability of the stromal cells to maintain and expand HSCs 
and hematopoietic progenitors by both in vivo competitive 
reconstitution assay and in vitro colony-forming assay.  
Aim 2. Characterize stromal cells and determine their cellular identity. 
To determine cellular characteristics of stromal cells by examination of their 
cell surface markers, gene expression, as well as their cell morphology. as well 
their expression profile of hematopoiesis-supportive growth factors. 
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Aim 3. Identify key factors that may regulate HSC self-renewal and 
expansion by transcriptome analysis of the isolated stromal cells. 
a. To elucidate genes differentially regulated in stromal cells compared to 
the non-HSC-supportive cell populations from the same tissue through 
computational analysis of transcriptome data. 
b. To functionally test the candidate genes that are identified through the 
microarray analysis. 
Specific Aim 1 will establish a novel approach to isolate stromal cells from 
early stage hematopoietic tissues by the identification of novel surface makers 
for stromal cells. Aims 2 and 3 will further characterize the HSC niches 
regarding the interaction between HSCs and the stromal cells.  
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CHAPTER TWO: MATERIALS AND METHODS 
2.1 Mice 
ICR (CD-1) mice were obtained from commercial stock at the Biological 
Resource Centre (BRC), and were used mainly for gene expression analysis 
and co-culture of bone marrow cells and yolk sac Dlk1+SSChi cells.  
Tg(AFP-GFP) transgenic mice were gifts from Margaret Baron (Mount Sinai 
School of Medicine, New York), and were used for harvesting fetal liver and 
yolk sac endoderm cells as well as for visualization of yolk sac endoderm cells.  
C57BL/6J (CD45.2) mice were obtained from commercial stock at the 
Biological Resource Centre (BRC). C57BL/6J (CD45.1) mice were a gift of 
Dr. Motomi Osato (Cancer Science Institute of Singapore).  Mice of the 
C57BL/6J background were used for competitive reconstitution experiments 
as either donors or recipients.   
For embryo generation, female mice were exposed to male mice overnight. 
Vaginal plugs were examined the following morning and were used as an 
indication for the pregnant stage of 0.5 days after coitus (dpc). 
All mouse work was carried out with approved Institutional Animal Care and 
Use Committee (IACUC) protocols at the Biological Research Centre (BRC) 
mouse facility at Biopolis.  
2.2 Isolation of primary yolk sac endoderm cells 
Embryonic yolk sac at E9.5 or E10.5 was carefully dissected from pregnant 
mice in Iscove's Modified Dulbecco's Medium (IMDM) supplemented with 
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20% fetal bovine serum (FBS). Harvested yolk sacs were digested with 0.1% 
trypsin/EDTA (Roche Applied Science, Indianapolis, IN) for 5 minutes at 
37°C with gentle pipetting at 1-minute intervals. Cells were washed twice with 
IMDM containing 20% FBS. Cell clumps were removed by pouring cells 
through a 70-m nylon mesh (BD Biosciences, Discovery Labware, Bedford, 
MA), then cells were centrifuged, washed, and incubated with a FITC-
conjugated Dlk1 antibody (MBL, Woburn, MA). The stained samples were 
analyzed using a LSR II FACS analyzer (Becton Dickinson).  For FACS 
analysis of the stromal population, E9.5 or E10.5 yolk sac cells were stained 
the same way as above and sorted for desired populations by a custom Aria 
FACS sorter (Becton Dickinson, Franklin Lakes, NJ).  
2.3 Purification of hematopoietic stem and progenitor cells from adult 
bone marrow 
Total bone marrow cells were first treated with ammonium chloride to lyse 
erythrocytes. The remaining cells were stained with APC-conjugated CD150 
(1:100; Biolegend,  San Diego, CA), FITC-conjgated CD48 (1:300; Biolegend) 
and FITC-conjugated CD41 antibodies (1:100; Ebioscience, San Diego, CA). 
CD150+CD48–CD41– HSCs and CD150-CD48+CD41- progenitors were sorted 
as described previously. 
2.4 Culture of bone marrow hematopoietic stem cells and progenitors. 
We isolated purified bone marrow CD41-CD150+CD48- HSCs or lin-CD150-
CD48+ progenitor cells from C57BL/6 and by flow cytometric cell sorting. We 
supplemented liquid suspension cultures of total bone marrow cells or bone 
marrow HSCs with IMDM plus 10% FBS, 1% penicillin-streptomycin, 20 
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ng/l thrombopoietin (TPO), 125 ng/l stem cell factor and 50 ng/l Flt-3 
ligand (TSF) with or without recombinant (human) midkine (R&D Systems, 
Minneapolis, MN). We set up noncontact yolk sac endoderm cell co-cultures 
using 0.4-μm transwell inserts (Corning).  
2.5 Co-culture assay 
Purified primary  Dlk1+SSChi endoderm cells from 10.5 yolk sac were plated 
on gelatin-coated 96-well or 24-well dishes (Becton Dickinson, Bedford, MA) 
in 100L IIMDM containing 15% FBS, 2 L L-glutamine, 5 ng/L Flt3, 100 
ng/L thrombopoietin (TPO), 10 ng/L interleukin 6 (IL-6)., and 50 ug/L 
stem cell factor (SCF). Cells were incubated at 37°C in a 5% CO2, 3% O2, and 
92% N2 humidified environment. To these endoderm monolayers, total bone 
marrow cells or bone marrow CD150+CD48-CD41- HSCs were added and the 
co-cultures at 37°C in a 5%CO2, 5%O2, and 90% N2 humidified environment 
for 4days or 7 days with or without addition 10 ng/L IL-6. Adult total bone 
marrow cells or bone marrow CD150+CD48-CD41- HSCs cultured on gelatin 
in the presence or absence of growth factors but without any endoderm cells 
were used as controls. 
2.6 Assays for hematopoietic colony-forming cells 
Bone marrow progenitors were sorted as described above. Total yolk sacs 
were obtained through dissection. Cells were dissociated and plated in 
triplicate in 0.9% methylcellulose culture with IMDM containing 15% FBS, 
1% conditioned medium of kit ligand (Kitl) supernatant, 1% conditioned 
medium of interleukin 3 (IL-3) supernatant, 3 ng/m l granulocyte macrophage 
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colony-stimulating factor (GM-CSF), 5 ng/ml interleukin 11 (IL-11), 4 U/L 
recombinant human erythropoietin (EPO) (Epogen, Amgen, CA), 0.5% 
ascorbic acid, and 2 M L-glutamine (Invitrogen, Carlsbad, CA). Cultures 
were incubated in a humidified incubator at 37°C in 5% CO2 and colonies 
were counted on day 4 and day 10.  
2.7 Transplantation 
C57 BL/6 recipient mice were lethally irradiated on the day of transplantation 
at 9 Gy. Control donor cell injections included freshly sorted bone marrow 
CD150+CD48–CD41– HSCs (300) plus freshly isolated 2 x 105 competitor 
cells were coinjected. The other recipient mice were injected with HSCs 
without culturing or cultured them with TSF alone, TSF plus midkine, TSF. In 
all studies, 6 to 10 recipient mice were injected for each test or control sample. 
At various times after transplantation, peripheral blood was collected from the 
tail vein of each mouse in heparinized tubes and assessed for the presence of 
CD45.2 or CD45.1 (donor cell derived) expressing cells. Red blood cells were 
lysed with red cell lysis buffer (Sigma-Aldrich, St. Louis, MO), and the 
nucleated cells were labeled with FITC-conjugated anti-CD45.2 mAb for 30 
minutes on ice. The cells were then washed and analyzed on a FACSCalibur 
machine (Becton Dickinson) for enumeration of donor-derived cells. We 
measured multilineage hematologic reconstitution in the peripheral blood by 
flow cytometry over time after transplantation as previously described (Kiel et 
al., 2005). Peripheral blood cells were suspended in Fc-blocking solution 
followed sequentially on ice by fluorescein isothiocyanate (FITC)–conjugated 
lineage-specific rat antimouse mAbs (anti-B220, anti-CD11b, anti-Mac-1, 
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anti-Thy1.2, anti–Gr-1) (1:100), and phycoerythrin (PE)–conjugated anti-
CD45.2 or anti-CD45.1  mAb (1:100; BD Pharmingen) for 30 minutes on ice. 
Cells were isolated using a FACStar instrument (BD Pharmingen). 
2.8 May-Grunwald Giemsa staining 
A suspension of cells was prepared in PBS with 2% FCS at a concentration of 
0.5–1 x 106 cells/ml. 5x104 cells were centrifuged onto glass slides using 
Cytospin 4 (Shandon, Fisher Scientific, Loughborough, UK). The cells were 
air dried completely and fixed in -20 °C methanol for 2 minutes. Benzidine 
solution was prepared by dissolving one benzidine tablet (Sigma, D5905) in 
10 mL PBS and filtered through a 0.22 micron filter. 10 μL of 30% Hydrogen 
peroxide solution (Calbiochem) was added to the Benzidine solution just 
before staining, and placed as drops directly on fixed cells for 2 hours at room 
temperature. The cells were rinsed briefly with PBS and stained 22 with 1:20 
dilution of Giemsa (Sigma, GS500) in water for 15 minutes at room 
temperature. Excess Giemsa stain was removed by washing with PBS. Images 
were captured on an Olympus BX51 microscope equipped with an Olympus 
DP70 digital camera using DPController image capture software (Olympus). 
2.9 Quantitative real-time polymerase chain reaction (qRT-PCR) 
Total RNA from sorted cells was obtained using a standard microkit extraction 
procedure as outlined in the manufacturer’s protocol (Qiagen). cDNA was 
synthesized as described above. The resulting material was used as template. 
The reaction mix was prepared as: 10 µl 2x SYBR Green PCR Master Mix, 
0.5 µl forward primer (10 µM), 0.5 µl reverse primer (10 µM), 1 µl template 
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and 8 µl water. The reaction solution was  denatured at 95°C for 5 minutes, 
followed by 35 cycles of amplification consisting of 94°C for 30 seconds 
(denaturing), 55°C for 30 seconds (annealing), and 72°C for 2 minutes 
(extension), and 72°C forever. 
Primers for validation of microarray results 
Genes mRNA No.   Sequence 
SCF/Kitl NM_013598.2 Forward AGCGCTGCCTTTCCTTATG 
    Reverse GTCACAGGATTCCCGCAG 
TPO NM_001173505.1 Forward ACAGAGCAAGGCACAGGACATTCT
    Reverse TTGTTGCAAGCTCAAGAAGAGGGC 
 
Genes upregulated in Dlk1+SSChi 

























Genes upregulated in Dlk1+SSChi and Dlk1+SSClo  
Genes mRNA No.   Sequence 
Bmp7 NM_007557.2 Forward TCACAGTCTATCAGGTGCTCC 
    Reverse CCTGCCAACTTGGGGTTGA 
Apoe NM_009696.2 Forward CTGACAGGATGCCTAGCCG 
    Reverse CGCAGGTAATCCCAGAAGC 
32 
 
Genes mRNA No.   Sequence 
Cmtm8 NM_027294.2 Forward TACCAGCTCCTTTGCGGAGAACTT 
    Reverse CAGCCACAAACATTACCCAGCCAA 
Pdgfb NM_011057.2 Forward TGAAATGCTGAGCGACCACTCCAT 
    Reverse AGTGTGCTCGGGTCATGTTCAAGT 
Igfbp5 NM_010518.2 Forward ACGGCGAGCAAACCAAGATAGAGA
    Reverse TCAGCTTCTTTCTGCGGTCCTTCT 
Igfbp2 NM_008342.2 Forward CCTCAAGTCAGGCATGAAGGA 
    Reverse GCAGGGAGTAGAGATGTTCCA 
Cxcl16 NM_023158.6 Forward ACCCTTGTCTCTTGCGTTCTTCCT 
    Reverse ATGTGATCCAAAGTACCCTGCGGT 
Cmtm6 NM_026036.3 Forward TGTGAAGAGGTTGTGTCCGAGTGT 
    Reverse CATGGAGCTTGCCAAGAAGCCAAA 
Mdk NM_001012335.1 Forward TACGCTGAGACATCGGTTCCAAGT 
    Reverse GCTGCCCTTCTTCACCTTCTCTTT 
Igf2bp1 NM_009951.3 Forward ACCACCAGAAACACCTGACTCCAA 
    Reverse ATTCTTCCCTGGGCCTTGAACTGA 
Ppbp NM_023785.1 Forward TAACCTCCAGATCTTGCTGCTGCT 
    Reverse TGGCCTGTACACATTCACAAGGGA 
Wnt2 NM_023653.4 Forward GTGGCACTGGCTTCACTGTA  
    Reverse GGGAAGTCAAGTTGCACACA  
Tnfsf14 NM_019418.1 Forward AGCAGCACATCTTACAGGAGCCAA 
      Reverse TGCGCTTGTATAGTCCATGGGTGA 
 
Genes upregulated in Dlk1+SSClo and OP9 
Genes mRNA No.   Sequence 
Ptn NM_008973.2 Forward TTGGAGCTGAGTGCAAGTACCAGT 
Reverse TCTTCTTTGACTCCGCTTGAGGCT 
Fstl1 NM_008047.4 Forward CACGGCGAGGAGGAACCTA 
Reverse TCTTGCCATTACTGCCACACA 
Csf1 NM_007778.3 Forward AGTCAACAGAGCAACCAAACC 
Reverse CAAAAATCCCTCACTAGCCTCTC 
Tgfb3 NM_009368.2 Forward TGGGTCTGGAAATCAGCATCCACT 
Reverse TCATGAGGATCAGGTGTGGGTTGT 
Jag1 NM_013822.4 Forward GCTTCGGCTCAGGGTCTAC 
Reverse GGCGAAACTGAAAGGCAGTA 
Vegfc NM_009506.2 Forward TTCCTGCCGGTGCATGTCTAAACT 
Reverse TCTTCATCCAGCTCCTTGTTGGGT 
Angptl2 NM_011923.4 Forward ACTTCTTCAGGAACTGGGAGACCT 
Reverse AGTCGGAAACTGGCATACTCAGCA 
Angpt1 NM_009640.3 Forward TGCACTAAAGAAGGTGTTTTGCT 
Reverse CCTCCCCCATTCACATCCATATT 




Genes mRNA No.   Sequence 
Hgf AK052289 Forward CCTGACACCACTTGGGAGTA 
Reverse CTTCTCCTTGGCCTTGAATG 
Ogn NM_008760.2 Forward CCTGGATGGGAAAAGTATTAAGG 
Reverse AGCAGACACACAACAGGCAT 
Tgfb2 NM_009367.2 Forward GCTTTGGATGCTGCCTACTGCTTT 
Reverse TGTACAGGCTGAGGACTTTGGTGT 
Cmtm7 NM_133978.1 Forward GTTCAAAGTGGCGCAGATG 
Reverse CATTATCAGGTCGCACATGG 
Wnt5b NM_009525.2 Forward CTGCTGACTGACGCCAACT 
Reverse CCTGATACAACTGACACAGCTTT 
Plat NM_008872 Forward GCAAGAGTGGGAAAGAAGCA 
Reverse AAAGCCAGTCCACAAAGCAG 
Thbs1 NM_011580.3 Forward AAAGGTGTCCTGTCCCATCA 
Reverse GTCCACTCAGACCAGGGAGA 
Cxcl1 NM_008176.1 Forward CCACACTCAAGAATGGTCGC 
Reverse TCTCCGTTACTTGGGGACAC 
IL1RN NM_031167.3 Forward GTGAGACGTTGGAAGGCAGT 
Reverse GCATCTTGCAGGGTCTTTTC 
Inhba NM_008380.1 Forward GCGATCAGAAAGCTTCATGTGGGT 
Reverse TCAAAGTGCAGTGTCTTCCTGGCT 
Pdgfc NM_019971.2 Forward AAGTTGAGGAGCCCAGTGATGGAA
Reverse AACACCGAAGGACTCGTGGTTTCT 
Clec11a NM_009131.2 Forward GAAGAGGAAATCACCACAGCA 
Reverse CCAAGCGGCCCAAGATGTAA 
IL-6 NM_031168.1 Forward GATGGATGCTACCAAACTGGA    
Reverse TCTGAAGGACTCTGGCTTTG 
Itgb1 NM_010578.1 Forward ACACCGACCCGAGACCCT       
Reverse CAATCCAATCCAGGAAACCA     
Tslp NM_021367.1 Forward ACGGATGGGGCTAACTTACAA 
Reverse AGTCCTCGATTTGCTCGAACT 
Dtx2 NM_023742.1 Forward TCAAGATGGGAGCTCAGACA 
Reverse TTGCAGGTTCAGGTTCATTG 
Ctgf NM_010217 Forward CCCTAGCTGCCTACCGACT 
Reverse CATTCCACAGGTCTTAGAACAGG 




Genes upregulated in Dlk1+SSChi, Dlk1+SSClo and OP9 
Gene mRNA No.   Sequence 
Eps8l2 NM_133191.2 Forward CCCGACATAGCACGCTCTG 
Reverse GGCACATAGAGTGGCACCT 
Lamb2 NM_008483.2 Forward CATGTGCTGCCTAAGGATGA 
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Gene mRNA No.   Sequence 
Reverse TCAGCTTGTAGGAGATGCCA  
Lama5 NM_001081171.2 Forward TTCATGCTGGACACGGCAGTAGAT 
Reverse CTTCTCAAAGCTGATGCGGGCAAA 
Efnb1 NM_010110.2 Forward ACCAGGAAATCCGCTTCACCATCA 
Reverse ACAGCATTTGGATCTTGCCCAACC 
Emp1 NM_010128.4 Forward AAGAGAGGACCAGACCAGCA 
Reverse CCACAAAGAGACCAGCCAGT 
Pdgfa NM_008808 Forward TGCCCATTCGCAGGAAGAGAAGTA 
Reverse TGACATACTCCACTTTGGCCACCT 
Mfge8 NM_008594 Forward ATGCTACTCTGCGCCTCTG 
Reverse AGATGTCATTGTCTTGGCCC 
Igfbp4 NM_010517.2 Forward AACTTCCACCCCAAACAGTG 
Reverse TACAACCCCAGAGCATAGGG 
Angpt2 NM_007426.3 Forward CAGCCACGGTCAACAACTC 
Reverse CTTCTTTACGGATAGCAACCGAG 
Il15 NM_008357.1 Forward ATCGCCATAGCCAGCTCATCTTCA 
Reverse AGACCTACACTGACACAGCCCAAA 
Neo1 NM_008684.1 Forward CAAACCTCCAATGAGTGGCAGCAA 
Reverse CTGATTTGCACGCAGCTCGTTTCT 
Gpi1 XM_001004276.1 Forward ACACGGCCAAAGTGAAAGAG 
Reverse GCTCGAAGTGGTCAAAACCT 
Bmp1 NM_009755.2 Forward AAAGGACCCGACTCAGCAAG 
Reverse CCATTGGGATACTCAGGGGAG 
Pxn NM_134152.3 Forward TGCACCTTTCAGGACAGTGAGGAA 
Reverse ATTGGTTGCATACACGAGCTGCAC 
Cx3cl1 NM_009142.3 Forward CGCGTTCTTCCATTTGTGTA 
Reverse TAGCTGATAGCGGATGAGCA 
Vegfa NM_001025250.2 Forward ATCAAACCTCACCAAAGCCAGCAC 
Reverse TTTCTCCGCTCTGAACAAGGCTCA 
Tgfbi NM_009369.1 Forward CAGCACGGCCCCAATGTAT 
Reverse GGGACCTTTTCATATCCAGGACA 
Gas7 NM_008088.1 Forward ACATCAAGAAGGCACGGAGGAAGT 
Reverse GCTCGACTGTGCTTTGGTTGAACA 
LTBP4 NM_175641.1 Forward GCTATCAGCCTACACCAGGG 
Reverse GTAGCCTTGGTCACAGACGC 
Bmp4 NM_007554.2 Forward GACTTCGAGGCGACACTTCTA 
Reverse GCCGGTAAAGATCCCTCATGTAA 
Efemp2 NM_021474.2 Forward TAACCAGGGCTATGAGCTGC 
Reverse GTGGGCAGTGACAGGAGAAT 
Il33 NM_133775.1 Forward ATCACGGCAGAATCATCGAG 
Reverse GCGGTGCTGCTGAACTTT 




Gene mRNA No.   Sequence 
Igf2bp3 NM_023670.2 Forward AAGCAGGGCCAACACATCAAACAG 
Reverse CCCAATAACTCTGCCAGCAGCAAA 
Grn NM_008175.3 Forward TGCTGCATTATGGTTGATGGT 
Reverse TGAAACGCATCGTGTGTGAAC 
Ccl7 NM_013654.2 Forward TCTGTGCCTGCTGCTCATAG 
Reverse TTCCTCTTGGGGATCTTTTG 
Tnc NM_011607.1 Forward ACGGCTACCACAGAAGCTG 
Reverse ATGGCTGTTGTTGCTATGGCA 
Gas6 NM_019521.2 Forward TCATGGGCAACTTCTTCTGCGTGT 
Reverse GAAGCTTCCTGGTTTGTTGTGGCA 
Tmeff1 NM_021436.1 Forward TCACCCATGTTCTTATCGCAGCCA 
Reverse AAATGACCCAGGTTCTGCTTCTGC 
Il18 NM_008360.1 Forward GTGAACCCCAGACCAGACTG 
Reverse CCTGGAACACGTTTCTGAAAGA 
ERBB2IP XM_358312.1 Forward TGGATTGAGAGAGTTTTGGATGG 
Reverse AAAGTCCTGGGGGTTTTCACA 
Vegfb NM_011697.2 Forward GCAACACCAAGTCCGAATGCAGAT 
Reverse TCTGGCTTCACAGCACTCTCCTTT 
Igfbp7 NM_008048.2 Forward AAGGACATCTGGAACGTCACTGGT 
Reverse ACCCAGCCCGTTACTTCATGCTTT 
NRADD NM_026012.2 Forward CCTAGCTGAGTGGATCCTGG 
Reverse ACTGAGTTGACGGAGCTTGG 
Lamb1-1 NM_008482.2 Forward GGTGTCCTAGCCCTATGGGG 
Reverse GCTCTGGTTTGTGCAGTCC 
Mif NM_010798.2 Forward TGCCCAGAACCGCAACTACAGTAA 
Reverse AACACAGAACACTACGTGGAGCGA 
Atrn NM_181415.3 Forward AAGAAATGCATCTCAGCCAGCAGC 
Reverse TTCCAGCCTTCTCCACAAAGGTGA 
Wnt5a NM_009524.2 Forward AGCCTGTAAGTGTCATGGAGT 
Reverse CGCGGCGCTATCATACTTCT 
Cxcl12 
(beta) NM_013655.2 Forward TGCATCAGTGACGGTAAACCA 
Reverse TGCACACTTGTCTGTTGTTGTT 
 
2.10 RNA extraction 
FACS sorted cells or tissues obtained from mouse embryos were lysed in a 
Guanidine-thiocyanate-containing lysis buffer. Total RNA was extracted and 
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further purified with the RNeasy Mini Kit or Micro Kit (Qiagen) according to 
the manufacturer’s instructions.  
2.11 cDNA synthesis 
To generate the kinetic gene expression profiles of early stage embryonic 
hematopoietic tissues, 1g total RNA of each type of tissue was used to 
synthesize cDNA. For FACS sorted cells, no less than 300 ng total RNA of 
each sample was used for cDNA synthesis.  The one-tube reverse 
transcription-PCR was carried out following a two-step protocol. First, 1 l of 
1X pd(N6), 1 l of 10 mM dNTPs, RNA and H2O topped up to 13 l total 
volume was mixed and reacted using the thermal cycler  for 5 minutes at 65°C, 
then quickly chilled on ice.    For the second step, add the following components 
into the product from the first step: 4 l of 5X 1st strand buffer, 1 l of 0.1 M 
DTT, 1 l of RNA guard, and 1 l of Superscript II RT. Synthesis reactions were 
incubated in a PCR thermal cycler at 25°C for 5 minutes followed by 37°C for 1 
hour. The cDNA samples were stored at -20°C if not used on the same day 
following synthesis.  
2.12 Gene expression microarrays and data analysis 
Total RNA was extracted from 3 biological replicates of the cells for 4 types 
of cells including Dlk1-, Dlk1+SSChi, Dlk1+SSClo and OP9 cells with RNeasy 
mini kits and 500 ng was reverse transcribed into cDNA followed by in vitro 
transcription to biotin-labeled cRNA using the Illumina TotalPrep RNA 
Amplification kit (Applied Biosystems). 750 ng of each cRNA sample was 
hybridized to MouseRef-8 v2.0 Expression BeadChip microarrays (Illumina, 
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San Diego, CA) and scanned on the BeadArray Reader (Illumina) at 25 scan 
factor 1. Background subtraction was applied on raw intensity values and 
subsequent data was subjected to quantile normalization on the Beadstudio 
Data Analysis platform (Illumina) with a normalized expression value cutoff 
at 100. Differentially expressed genes were identified based on an at least 2-
fold change in at least one condition compared to controls. Individual gene 
lists were uploaded into Ingenuity Pathway Analysis software (Ingenuity 
System) to identify the significantly enriched gene ontology categories based 
on molecular and cellular functions. The significance of the association 
between the dataset and the canonical pathway was measured and displayed in 
2 ways: ratio of the number of genes from the data set that map to the pathway 
divided by the total number of genes that map to the canonical pathway, and 
Fischer’s exact test was used to calculate a p-value determining the probability 
that the association between the genes in the dataset and the canonical 
pathway is explained by chance alone. Microarray data was deposited into 
Gene Expression Omnibus. 
2.13 Statistical analysis. 
Student’s t-test was used to determine the significance of differences between 
treated samples and controls. Statistical analysis was performed using 
Microsoft Office Excel 2010. Data are expressed as the means ± s.d. or s.e.m  
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CHAPTER THREE: RESULTS PART I 
3.1 Yolk sac primitive endoderm cells serve as stromal cells supporting 
expansion of hematopoietic progenitors 
3.1.1 Expression profile kinetics of fetal liver-derived HSC-supportive 
growth factors in early hematopoietic tissues 
A recent study showed that fetal hepatic stem or progenitor cells purified 
based on the surface antigens SCF+Dlk1+, are capable of supporting the 
maintenance of HSCs in ex vivo cultures (Chou and Lodish, 2010). These fetal 
liver stromal cells produce high levels of mRNA encoding several HSC-
supportive growth factors, including Angptl3, Igf2, Kitl/SCF and Tpo (Chou 
and Lodish, 2010). To investigate whether other embryonic hematopoietic 
tissues contain potential HSC supporting stromal cells producing the 
same/similar set of growth factors as these fetal liver stromal cells, we 
harvested AGM, yolk sac, fetal liver and placenta tissues from mouse embryos 
ranging from E7.5 to E14.5, and performed quantitative PCR (qPCR) to 
determine the levels of Angplt3, Igf2, Kitl/SCF and Tpo. Igfbp1, a putative 
HSC-supportive factor, was also included due to its sequence similarity 
(34.3% identity) with Igfbp2 that has been shown to stimulate ex vivo HSC 
expansion. (Huynh et al., 2008). Dlk1/Dll1 was also included in the analysis 
since it was used as a surface marker to purify stromal cells from fetal liver. 
Moreover, previous studies also demonstrated Dlk1/Dll1, a membrane-bound 
cytokine, is able to promote maintenance and self-renewal of HSCs (Moore et 
al., 1997c; Li et al., 2005). Afp was also tested, since it specifically marks 
hepatic stem/progenitor cells and was found to be expressed at an intermediate 
level by fetal liver stromal cells (Oertel et al., 2008). In addition, Afp was also 
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demonstrated  to be a marker for both primitive and definitive endoderm 
lineages during mouse development (Kwon et al., 2006).  
During embryonic development, expression of Angplt3 and Igfbp1 mRNA 
transcripts increased gradually in all the hematopoietic tissues. Higher relative 
expression levels of these two genes were observed in the yolk sac and fetal 
liver at all developmental stages (Figure 3-1). In contrast, total mRNA 
transcript levels of Tpo, Igf2 and Kitl/SCF within each tissue remained fairly 
constant throughout development. Again, a higher level of Tpo mRNA was 
observed in the yolk sac and fetal liver compared with the AGM and placenta 
(Figure 3-1). 
Dlk1/Dll1 expression in the yolk sac, AGM and fetal liver is similar to that of 
Igf2, which maintains at similar level during development. However, little or 
no expression was found in the placenta (Figure 3-2). The Afp expression 
profile shares significant similarity with that of Angplt3 and Igfbp1 in terms of 
both trends of change during development and relative levels among different 
tissues. The expression of Afp mRNA is especially high in the yolk sac and 
fetal liver, and this result reflects the fact that both tissues contain cells of 
primitive/definitive endoderm origin (Figure 3-2).  
The increasing expression of Angplt3, Igbp1 and Afp suggests that higher 
amount of these factors may be required to meet the needs of the developing 
embryos. In contrast, constant levels of Tpo, Igf2, Kitl/SCF and Dlk1 might be 





Figure 3-1.  Kinetic expression pattern of the HSC-supportive growth 
factors during development shows similarity between yolk sac and fetal 
liver.   
Reverse transcription (RT)-qPCR analysis was performed to determine the 
relative expression levels of HSC-supportive growth factors in fetal liver 
(blue), AGM (red), yolk sac (green) and placenta (purple) from E7.5 to E14.5. 
Gene expression levels were normalized to actin. Triplicates were tested for 





Figure 3-2.  Kinetic gene expression profiles of endoderm markers shows 
high expression by both yolk sac and fetal liver.   
Reverse transcription (RT)-qPCR analysis was performed to determine the 
relative expression levels of HSC-supportive growth factors in fetal liver 
(blue), AGM (red), yolk sac (green) and placenta (purple) from E7.5 to E14.5. 
Gene expression levels were normalized to actin. Triplicates were tested for 











The striking similarity between growth factor expression profiles of yolk sac 
and fetal liver led to our hypothesis that the yolk sac may contain similar 
stromal cells as that in the fetal liver, and might be purified using the same 
markers.  
We also focused on the developmental stages E9.5 and E10.5 to identify the 
potential stromal cells. Our decision was based on the following reasons: first, 
our gene expression profile shows that mRNA levels of the assessed growth 
factors peaked at around E9 to E10, and remained high thereafter in the yolk 
sac; secondly, a previous study showed that between E9.5 and E10.5, there is a 
huge expansion of hematopoietic progenitors in the yolk sac (Figure 1-4) 
(Palis et al., 1999b), which suggests that a large amount of growth factors 
produced during these stages might be required to meet the needs of the 
proliferating progenitors; in addition, upon establishment of circulation at E8.5, 
adult-repopulating HSCs start to emerge in the yolk sac (Figure 1-3) (Mikkola 
et al., 2005b), which implies that the microenvironment of the yolk sac after 
that stage might also provide suitable conditions to maintain or even expand 
HSCs when circulating stem cells encounter the niche.  
3.1.2 E10.5 yolk sac Dlk1+SSChi population expresses high level of HSC-
supportive growth factors 
In an effort to purify the growth factor-expressing cells from the yolk sac, we 
first attempted to isolate a cell population that has the surface phenotype of 
Kitl/SCF+, which is one of the two markers used to purify fetal liver hepatic 
stromal cells. However, few cells (about 0.7%) in the E9.5 yolk sac were 
identified by the biotinylated Kitl/SCF antibody (Figure 3-3A). qPCR data 
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showed that the Kitl/SCF+ population was not enriched for the growth factors 
transcripts, and it was even true for Kitl/SCF itself (Figure 3-3B). Fluorescent 
conjugates of streptavidin staining control further pointed out that the 
Kitl/SCF+ population being sorted was actually cells with non-specific 
staining, which can be inferred from the low but similar level of positive cells 
(about 0.6%) in the control sample (Figure 3-3A). The same experiments were 
also carried out on the E10.5 yolk sac, and similar results were also obtained 
(data not shown). To rule out the possibility that the SCF antibody does not 
work properly, E14.5 fetal liver cells were sorted using the antibody and found 
to bind to SCF on the surface of fetal liver cells, qPCR analysis of the 
Kitl/SCF+ cells shows an enrichment of mRNA for Kitl, Angptl3, Igfbp1 and 
Igf2 but not Tpo (Figure 3-4). Therefore, this means that the membrane-bound 
form of Kitl/SCF might not be present on the surface of yolk sac cells, so that 






Figure 3-3.  Kitl/SCF positive cells of E9.5 yolk sac are not enriched for 
mRNA of the HSC-supportive growth factors and fetal liver stromal cell 
markers. 
(A) Isolation of Kitl/SCF+ cells from E9.5 yolk sac. ~0.7% cells located in the 
Kitl/SCF+ gate (left), whereas ~0.6% cells detected were selected due to non-
specific staining by the fluorescent conjugates of streptavidin (right).  (B) 
qPCR result shows that Kitl/SCF+ cells produce low levels of HSC-supportive 
growth factors and fetal liver stromal cell markers. Gene expression levels 
were normalized to actin, and fold enrichment were calculated relative to 







Figure 3.1-4.  Kitl/SCF positive cells of E14.5 fetal liver are enriched for 
mRNA of the HSC-supportive growth factors and fetal liver stromal cell 
markers. 
(A) Isolation of Kitl/SCF+ cells from E14.5 fetal liver. ~2.5% cells located in 
the Kitl/SCF+ gate (left), whereas ~0.0% cells detected were selected due to 
non-specific staining by the fluorescent conjugates of streptavidin (right).  (B) 
qPCR result shows that Kitl/SCF+ cells produce high levels of HSC-supportive 
growth factors and fetal liver stromal cell markers, except for Tpo. Gene 
expression levels were normalized to actin, and fold enrichment were 
calculated relative to Kitl-. Triplicates were tested for each data point, and 




Thus, we went on to test whether the other fetal liver stromal cell marker, 
Dlk1, can be used to isolate the growth factor-producing cells. By performing 
FACS analysis, we found that E10.5 yolk sac cells contain two distinct Dlk1 
positive populations with different size and granularity. We thus named them 
Dlk1+SSChi and Dlk1+SSClo subsequently (Figure 3-5A). The Dlk1+SSChi and 
Dlk1+SSClo cells constitute about 10% and 13% of total yolk sac cells 
respectively. Interestingly, similar to fetal liver stromal cells, yolk sac Dlk1+ 
cells are also enriched for mRNA expression of the HSC-expansion growth 
factors, with Dlk1+SSChi cells producing the highest level of all growth factors 





Figure 3-5.  Yolk sac growth factor-producing cells can be isolated using 
the fetal liver stromal cells marker Dlk1.   
(A) Based on Dlk1 expression and side scatter property, E10.5 yolk sac can be 
divided into three populations of cells, i.e. Dlk1-, Dlk1+SSChi and Dlk1+SSClo. 
(B) qPCR analysis  shows that Dlk1+SSChi cells produce the highest level of 
mRNA of HSC-supportive growth factors, and Dlk1+SSClo cells express 
intermediate to high levels of those growth factors. Gene expression levels 
were normalized to actin, and fold enrichment were calculated relative to 






3.1.3 Dlk1+SSChi cells are not endothelial or hematopoietic cells.  
Characerization studies were then carried out to further determine the lineages 
of the Dlk1+SSChi and Dlk1+SSClo cells. We co-stained the cells with other 
lineage markers, including endothelial vascular markers CD31 (Baldwin et al., 
1994), Tie-2 (Dumont et al., 1995), vascular cell adhesion protein 1 (Vcam-1) 
(Iiyama et al., 1999), hematopoietic markers CD41 (Ferkowicz et al., 2003b), 
CD45, CD34 and c-kit.  Yolk sac cells were separated into SSChi and SSClo 
populations based on their side scatter properties (Figure 3-6A) for FACS 
analysis individually. It is shown that a portion (6~10%) of Dlk1+SSClo cells 
co-express some of the hematopoietic  or endothelial markers, while only few 
(~3%) Dlk1+SSChi cells co-express endothelial (Figure 3-6B)  or 
hematopoietic markers (Figure 3-7).  This suggests that Dlk1+SSClo cells are a 
mixture of mutiple types of cells rather than a homogenous cell population. In 






Figure 3-6.  FACS analysis shows that Dlk1+ cells are not endothelial cells.    
(A) SSChi and SSClo cells were gated from total yolk sac cells for FACS 
analysis. (B) Surface expression of endothelial markers by Dlk1+SSChi cells 







Figure 3-7.  FACS analysis shows that Dlk1+ cells are not hematopoietic 
cells.   
Surface expression of hematopoietic markers by Dlk1+SSChi cells and 






3.1.4 Dlk1+SSChi cells do not contain hematopoietic progenitor cells 
To determine whether the Dlk1+ cells have hematopoietic potential, colony 
forming assays were performed on both total yolk sac cells and the three 
sorted populations. Results demonstrated that progenitor activity lies mainly in 
the Dlk1+SSClo population, while Dlk1+SSChi cells contain only a few 
macrophage progenitors, which could be spill-overs from other populations 
during cell sorting (Figure 3-9). No colony forming cells can be detected 
within the Dlk1- population which we later found to be Ter119+ erythroid cells 




Figure 3-8.  FACS analysis of E10 yolk sac cells shows that Dlk1- cells are 
Ter119+ erythroid cells. 
SSClo cells from E10 yolk sac were stained for both Ter119 and Dlk1. All 










Figure 3-9.  Colony-forming assay shows that the yolk sac hematopoietic 
progenitors are mainly included in the Dlk1+SSClo population.    
Colony-forming activity was tested in three populations of cells obtained from 
E10.5 yolk sac. The number of colonies was obtained from 8x104 sorted cells 
(means + s.d., n = 3 per group). CFU-E, colony -forming unit–erythroid 
progenitors; BFU-C, burst-forming unit–erythroid progenitors; CFU-Mac, 














3.1.5 Dlk1+SSChi cells have primitive endoderm-like morphological 
characteristics.  
To better understand the identity of the Dlk1+ cells, Giemsa staining was 
carried out on sorted yolk sac cells. First, SSChi and SSClo cells were 
differentiated by their side scatter. Previously, Dlk1- cells were also proven to 
be the Ter119+ cells, and all Dlk1+SSClo cells are Ter119- (Figure 3-8).  CD71 
was then employed as an additional marker to determine the differentiation 
stages of the Ter119+ (Dlk1-) cells, since differential expression of CD71 and 
Ter119 distinguishes cells in consecutive stages of terminal erythroid 
maturation (Zhang et al., 2003c). Because all Ter119+ (Dlk1-) cells are also 
positive for CD71 expression, it indicates that these cells are late stage 
erythroid cells (Figure 3-10). Thus, within the SSClo population, cells were 
further divided into CD71+Ter119+(Dlk1-) erythroid cells and Ter119-
(Dlk1+SSClo) cells (Figure 3-10) We observed that Dlk1+SSChi cells have a 
relatively homogeneous morphology, and they are distinctively different from  
CD71+Ter119+(Dlk1-) erythroid cells and Ter119-(Dlk1+SSClo) cells. 
Dlk1+SSChi cells are big in size, and have a small nucleus. More importantly, 
they contain complex vacuole structures, which is indicative of endodermal 
cells (Figure 3-10). The Dlk1+SSClo cells, represented by the Ter119+ cells, 
appear to have multiple cell types with different morphologies. The various 
cell types have different sizes, nuclei shapes and presence or absence of 
granules within the cytoplasm. The heterogeneous cell morphology of the 




Figure 3-10.  Giemsa staining of cells sorted from E10.5 yolk sac.   
Dlk1+SSChi cells are large in size, and contain complex vacuoles structure, 
identifying them as primitive endoderm cells.  Ter119- cells, an equivalent to 
Dlk1+SSClo cells, show heterogeneous morphologies, which demonstrates that 
it is a mixture of multiple types of cells. CD71+Ter119+ (Dlk1-) cells appear as 









3.1.6 Gene expression analysis showed that Dlk1+SSChi cells are visceral 
endoderm cells.  
To further confirm the endodermal identity of Dlk1+SSChi cells, microarray 
and qPCR analysis were performed. A list of genes to distinguish endoderm 
cells from other lineages was derived through literature review (Table 3-1). 
qPCR results showed that, amongst the genes examined,  Dlk1+SSChi cells are 
enriched for several endoderm markers, including pan-extraembryonic 
endoderm marker Gata4, primitive and visceral endoderm markers Dab2 and 
Foxa2, and parietal endoderm marker Sparc (Figure 3-11A).  Dlk1+SSClo cells 
also produce a high level of Sparc mRNA, indicating that the Dlk1+SSClo cells 
might contain some endoderm cells. Here, we also included SM22, a marker 
for yolk sac mesothelium in our analysis.  The yolk sac mesothelium is a 
derivative  from the mesoderm and has an important blood vessel modeling. 
SM22 mRNA was found to be present in the yolk sac mesothelium during 
development (French et al., 2008). qPCR results showed that 
SM22expression is mainly enriched in the Dlk1+SSClo cells, although low 
level of SM22mRNA can also be seen in the Dlk1+SSChi population. 
Similar results were obtained from microarray analysis, where mRNA 
expressions of visceral endoderm markers, Amn, Sdc4, Tmprss2, Pem and  
Hnf4were found be specifically high in the Dlk1+SSChi cells. Emp2, another 
marker for visceral endoderm was enriched by Dlk1+SSChi and Dlk1+SSClo 
cells (Figure 3-11B). In conclusion, the Dlk1+SSChi cell population contains  a 
majority of   visceral endoderm cells in the yolk sac, localize on the outer layer 
of the yolk sac, and also small amounts of  mesoendothelium cells.  In contrast, 
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the Dlk1+SSClo cell population  contains  a majority of mesoendothelium cells 




Table 3-1. Endoderm markers tested 
Gene Description and references 
Gata6 
Gata4 
Gata6 and Gata4 serve as pan-extraembryonic endoderm markers, 
since their expression marks the committed extraembryonic 
endoderm precursor (Chazaud et al., 2006; Kurimoto et al., 2006). 
In addition, both Gata factors can be used to induce extra-
embryonic endoderm cells from ES cells (Fujikura et al., 2002; 
Shimosato et al., 2007). 
Dab2  
Dab 2 is a primitive and visceral endoderm marker, and is required 
for normal embryo development by mediating endocytosis of 
megalin in the visceral endoderm during gastrulation. In addition, 
rescue of embryonic viability correlates with endocytosis, 
suggesting that endocytosis mediated by Dab2 is important for 
normal development (Maurer and Cooper, 2005).  
Foxa2 
Foxa2 is expressed in the extraembryonic endoderm, and it is 
important for proper morphogenesis during mouse embryogenesis 
(Suri et al., 2004). 
Sox7 
Sox7 is a marker for extraembryonic endoderm, and it can be used 
to discriminate extraembryonic from definitive endoderm (Kanai-
Azuma et al., 2002) 
Sparc 
Sparc is a parietal endoderm marker, its mRNAs were found to be 
restricted to the endoderm during embryo development (Koehler et 
al., 2009). 
Amn 
Amnionless (Amn) encodes a transmembrane protein that is 
specifically produced by visceral endoderm layer, and provides 
important signals to direct mesoderm production. Mice with 
disrupted Amn gene display embryonic lethal mutation, which is 
related to defects in specification of the primitive streak region 
during gastrulation (Kalantry et al., 2001).  
Sdc4 
Expression of Syndecan-4 (Sdc4) (Couchman and Woods, 1999) 
was found to be high in extraembryonic visceral endoderm, 
howevers, Sdc4 expression was not detected in definitive 
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Gene Description and references 
endoderm (Yasunaga et al., 2005).  
Emp2 Emp2 (epithelial membrane protein-2) (Wadehra et al., 2002) expression is high in visceral endoderm (Yasunaga et al., 2005).  
Tmprss2 
Tmprss2 (Vaarala et al., 2001) was detected in extraembryonic 
visceral endoderm but not definitive endoderm  (Yasunaga et al., 
2005).  
Pem 
Both Pem (Perea-Gomez et al., 2002; Tam et al., 2004) mRNA and 
protein was detectable only in extraembryonic tissues and was 
present in visceral endoderm in developing mouse embryos (Lin et 
al., 1994).  
Hnf4 
Mice with deletions in hepatocyte nuclear factor 4alpha (HNF4) 
(Duncan et al., 1994) have defects in visceral endoderm formation 








Figure 3-11.  Gene expression analysis reveals that Dlk1+SSChi cells are 
visceral endoderm cells. 
(A) qPCR results of expression of endoderm markers by Dlk1-,  Dlk1+SSChi 
and Dlk1+SSClo cells of E10.5 yolk sac. (B) Microarray results of visceral 












3.1.7 Immunofluorescence showed the pattern of location of growth 
factor-producing endoderm cells in the yolk sac 
To validate the gene expression analysis, immunofluorescence staining was 
carried out to visulize the growth factor-producing cells in the yolk sac. To 
this end, a transgenic mouse lines Tg(Afp-GFP) was used. In the Tg(Afp-GFP) 
mice, expression of green fluorescent protein (GFP) is driven by an Afp 
promoter/enhancer. Since Afp is a marker for yolk sac endoderm cells, GFP 
fluorescence allowed the visualization of these cells under microscope. In 
order to determine whether all HSC-supportive growth factors are produced by 
the same type of cells or different subsets of cells within the yolk sac, we 
performed immunofluorescence on cytospun yolk sac cells from Tg(AFP-GFP) 
mouse line. We first dissociated the whole yolk sac of Tg(AFP-GFP) mice 
into single cells, and then spun them onto glass slides.Through confocal 
microscopy, we observed that most AFP-GFP positive yolk sac visceral 
endoderm cells co-expresses HSC-supportive growth factors including 
Angplt3, Tpo and Igfbp1 (Figure 3-12).  Some AFP marked endoderm cells 
(yellow arrow) do not co-express the growth factors while a few AFP negative 
cells were found to produce the factors (white arrow). This pattern shows that 
endoderm cells are not the only cell type that secrets the HSC-supportive 
growth factors within the yolk sac. As qPCR showed that mRNA of the HSC-
supportive growth factors are enriched in both Dlk1+SSChi and Dlk1+SSClo 
cells (Figure 3-5B), if  Afp-GFP  positive  cells  represent  all endoderm cell 
of the yolk sac then the AFP negative growth factor-producing cells might 






Figure 3-12.  Immunofluorescence shows that most growth factor-
producing cells within the yolk sac are heterogeneous. 
E10.5 yolk sac from Tg(AFP-GFP) mice were dissociated and spun onto glass 
slide. PE-conjugated antibodies were used to visualize the expression of the 
growth factors by the yolk sac cells. A sub-population of AFP+ endoderm cells 
co-express Angptl3, Igfbp1, and Tpo. However, not all the AFP+ endoderm 
cells are producing the growth factors (yellow arrows), and there are other 






3.2 Function of yolk sac endoderm cells  
3.2.1 Yolk sac endoderm cells can support maintenance of Lineage−Sca-
1+c-kit+ (LSK) population during co-culture with total bone 
marrow cells 
Both gene expression profile and immunostaining of the growth factors show 
that primary yolk sac endoderm cells, the Dlk1+SSChi cells produce the 
hematopoietic growth factors. In order to examine the function of Dlk1+SSChi 
cells on HSCs and hematopoietic progenitor cells, co-culture experiments 
were carried out to determine if Dlk1+SSChi cells have any effects on the 
maintenance of bone marrow-derived cells.  
First, in order to optimize the bone marrow-derived cell culture conditions, 
several parameters, including plate type, plating density, plate coating, 
supplementary cytokines and culture media volume were tested. After 7 days 
culture of total bone marrow cells under various conditions, we performed 
FACS analysis to compare the resulting percentage of Lineage−Sca-1+c-kit+ 
(LSK) cells in each group (Figure 3-13) (results summarized in Table 3-2). 
Based on these series of experiments, the optimal culture conditions was 
determined based on the final LSK %, i.e. Group 2 & 5 (refer to Figure 3-13 & 
Table 3-2). In Group 2, bone marrow cells were plated on a gelatin-coated 24-
well tissue culture plate with seeding density of 7x103 cells per well in a media 
supplemented with TSF and IL-6, and it helped to maintain the LSK fraction 
to a relatively high level of 3.26%. Similarly, Group 5, an optimized condition 
for culture in 96-well plate, resulted in a final LSK% of 2.83%. Hence, these 





Figure 3-13.  FACS plots showing the percentage of LSK cells within the 
cultured bone marrow cells revealed the optimal culture conditions. 
FACS analysis showing the LSK cell percentage within the bone marrow cells 
before and after co-culture under various culture conditions. Culture 







Table 3-2. Summary of culture conditions and %LSK based on data 


















































































Using the optimal culture conditions, we co-cultured total bone marrow cells 
with purified yolk sac visceral endoderm cells, the Dlk1+SSChi cells (Figure 3-
14A). Whole bone marrow cells were collected from adult mice femur, and 
red blood cells were removed by ammonium chloride lysis. Remaining bone 
marrow cells were used in all co-culture experiments. Currently, the culture 
system contains serum and several cytokines, including Kitl/SCF, TPO and 
FLT3. In order to measure the effectiveness of the co-culture, the percentage 
of LSK cells within total bone marrow cells before and after culture were 
quantified (Figure 3-14B). Here, the result demonstrates that Dlk1+SSChi cells 
can stimulate proliferation of bone marrow-derived LSK cells as evidenced by 
the higher percentage of LSK cells after co-cultured with higher concentration 
of Dlk1+SSChi cells. 
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Figure 3-14.  Yolk sac visceral endoderm cells can stimulate expansion of 
LSK cells within total bone marrow during co-culture. 
(A) Schematic illustration of the experiment procedure. (B) FACS analysis 
of %LSK cells within total bone marrow cells before and after co-culture. On 
the histogram, lineage negative cells were first gated, and then analyzed for 
Sca1+c-kit+ cells. Numbers on the scatter plots indicates the percentage of 













In a separate co-culture experiment, we used the transwell culture system to 
physically separate the bone marrow and Dlk1+SSChi cells (Figure 3-15A). 
The transwell culture allowed us to test whether cell-cell contact plays a role 
in the co-culture. Cell proliferation rate was quantified during the co-culture. 
We can see that by adding Dlk1+SSChi cells into the culture system, bone 
marrow cells proliferate at a much faster rate compared to when they were 
cultured alone (Figure 3-15B). The rate of proliferation measured is not due to 
the Dlk+SSChi cells, since Dlk1+SSChi cells themselves do not seem to 
proliferate a lot in culture (Figure 3-15C).  
However, we observed diminished expression of LSK markers by the bone 
marrow cells after the co-culture, which indicates that bone marrow  cells 
undergo rapid differentiation during culture (Figure 3-16). This result indicates 
that cell-to-cell contact is an important prerequisite for the Dlk1+SSChi cells to 










Figure 3-15.  Bone marrow cells undergo proliferation during co-culture, 
while the number of yolk sac visceral endoderm cells remains the same.   
(A) Illustration of the transwell system used to separate Dlk1+SSChi cells and 
bone marrow cells. (B) Fold change of bone marrow cells after being cultured 






Figure 3-16.  FACS analysis of percentage of LSK cells before and after 
co-culture within the transwell system indicates that cell-cell contact is 
important.   
Culture and co-culture experiments were performed in the transwell system, in 
which the bone marrow cells were physically separated from the Dlk1+SSChi 
cells. On the histogram, lineage negative cells were first gated, and then 
analyzed for Sca1+c-kit+ cells. Numbers in the black box indicates the 













3.2.2 Yolk sac endoderm cells cannot support maintenance of HSCs in 
vitro through co-culture 
We were next interested to functionally examine whether the LSK cells 
expanded during  co-culture with yolk sac visceral endoderm cells have 
repopulating ability in irradiated receipent mice.  We enriched CD41-
CD150+CD48- HSCs (Figure 3-17) from adult bone marrow,  co-cultured them 
with Dlk1+SSChi  cells, followed by competitive transplantation experiments. 
Surprisingly, we observed that repopulating activity of the bone marrow cells 
is not  maintained by the yolk sac visceral endoderm cells, as seen from the 
decreased percentage of donor-derived periphral blood cells within the co-
cultured groups (Figure 3-18). Similar results were obtained for both short-
term culture period of 4 days and long-term culture period of 7 days. This 
result indicates that the current experimental parameters with the yolk sac 
visceral endoderm cells does not maintain the stemness of HSCs. Considering 
previous data that demonstrate visceral endoderm cells could support the 
growth of LSK cells (Figure 3-14B), it implies that the increased LSK cells are 








Figure 3-17.  Isolation of HSCs from adult bone marrow.   
Strategy used to isolate HSCs from adult whole bone marrow cells. Total bone 
marrow cells were depleted of red blood cells, and sorted for CD41-











































Figure 3-18.  Competitive repopulation results show that yolk sac visceral 
endoderm cells cannot maintain HSCs derived from adult bone marrow 
during co-culture.   
A total of 300 sorted bone marrow CD41-CD150+CD48- HSCs (CD45.2) were 
cultured in a serum-containing medium supplemented with Kitl/SCF, TPO, 
and FLT3 for 4 days or 7 days either without or with 3x105 sorted E10.5 yolk 
sac Dlk1+SSChi cells and were transplanted together with 2x105 helper cells 
into CD45.1 mice.  Freshly isolated HSCs were directly transplanted into 
CD45.1 mice as a control. Each dot, square or triangle represents a recipient 
mouse. Reconstitution is measured as percentage of CD45.2+ cells divided by 
total number of CD45.1+ plus CD45.2+ cells in the peripheral blood. Mean 




3.2.3 Yolk sac endoderm cells can support proliferation of 
hematopoietic progenitor cells from yolk sac and adult bone marrow 
Since Dlk1+SSChi cells can promote proliferation of LSK cells, but not adult-
repopulating HSCs, we then hypothesized that the cells being expanded during 
co-culture were hematopoietic progenitor cells. To test our hypothesis, we 
sorted progenitor cells from adult bone marrow as Lin-CD150-CD48+ cells 
(Figure 3-19), and performed colony-forming assay before and after co-culture.  
After 4 days in culture, total number of colony-forming units presented in the 
culture of progenitors alone is similar to that of the co-cultured cells. 
Interestingly, we found that yolk sac endoderm cells dramatically stimulate 
expansion of hematopoietic progenitors during co-culture when the culture 
period was prolonged to 7 days (Figure 3-20). This data suggests that 
Dlk1+SSChi cells, are able to support expansion of hematopoeitic progenitors, 







Figure 3-19.  Purification of hematopoietic progenitors from adult bone 
marrow.   
Strategy for isolation of hematopoietic progenitors from adult bone marrow. 
Cells being purified were Lin-CD150-CD48+, which represents about 8.3% of 





Figure 3-20.  In vitro assay provide evidence that yolk sac visceral 
endoderm cells can stimulate expansion of colony-forming hematopoietic 
progenitor cells derived from adult bone marrow in co-culture.   
Colony-forming activity was measured before and after co-culture for both 
shorter (4 day) and longer (7 day) periods. The number of colonies was 
obtained from 2x104 sorted progenitors or after culturing of these cells with or 
without Dlk1+SSChi cells (means ± s.d., n = 3 per group). CFU-Mast, colony –
forming unit–mast cell progenitors; CFU-GM, colony-forming unit–





CHAPTER FOUR: RESULTS PART II 
4.1 Midkine is identified through genome-wide transcriptome analysis 
as a putative novel growth factor for supporting HSCs  
As shown in Figure 3-4B, mRNA expression of several HSC-expansion 
growth factors were enriched in both Dlk1+SSChi and Dlk1+SSClo cells, 
leading to our hypothesis that other growth factors produced by these two cell 
populations might have HSC-supportive capability as well. In an effort to 
identify the soluble molecules being produced by the Dlk1+SSChi and 
Dlk1+SSClo cells, we performed genome-wide transcriptome analysis on these 
two yolk sac derived cell populations in comparison to the Dlk1- cells. In 
addition, we also included in our analysis, the OP9 stromal cell line (Kodama 
et al., 1994), which is a known stromal cell line supporting hematopoietic 
differentiation of embryonic stem cells (Nakano, 1995; Suwabe et al., 1998; 
Kitajima et al., 2003; Nakayama et al., 1998). This would aid in the 
identification of novel growth factors specifically being made by the HSC 
supporting yolk sac stromal cells.  
First, hierarchical clustering shows that triplicates of each sample were 
grouped in the same cluster (Figure 4-1A). In addition, Dlk1+SSClo cells are 
more similar to the OP9 cells than to Dlk1+SSChi cells. Dlk1+SSChi, 
Dlk1+SSClo and OP9 cells were clustered into the same group at a higher 
hierarchical level, suggesting that they may have similar biological functions 
such as serving as stromal cells supporting hematopoiesis. 
For the subsequent microarray analysis, we first compared the gene expression 
levels of various genes in Dlk1+SSChi, Dlk1+SSClo and OP9 cells with Dlk-1- 
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cells to obtain a list of preferentially upregulated genes in each cell type. 
Criteria for selecting upregulated gene are fold change bigger than 2 and p-
value less than 0.01. From the list of upregulated genes, various growth factors 
and cytokines were selected by Gene Ontology using several databases. These 
databases include the MGI-Gene Ontology, StromDB, and Ingenuity Pathway 
Analysis. As described above, three lists consisting of upregulated growth 
factors and cytokines in each cell population (compared to Dlk1-) was 




Figure 4-1.  Microarray analysis revealed growth factors being 
upregulated in yolk sac-derived stromal cells and OP9.   
(A) Hierarchical clustering analysis of differentially expressed genes among 
the 4 populations of cells. Each sample contained 3 biological replicates 
(termed Set A, Set B and Set C) that correlated well with each other. (B) 
Schematic representation of the strategy for construction of lists of 
upregulated growth factors in Dlk1+SSChi, Dlk1+SSClo, OP9 cells. 
Upregulated genes were selected based on the following criteria: P value < 
0.01; fold change > 2. 
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We then validated the lists of growth factors by performing qPCR analysis on 
the four cell populations, and then finalized our lists for the following study 
(Figure 4-3 – Figure 4-6). A Venn diagram was generated to show the 
overlaps in growth factors among the three upregulated growth factor lists 
(Figure 4-2). We observed that more than half of the growth factors enriched 
in the Dlk1+SSClo cells are also upregulated in the OP9 cells.  Moreover, 32 
growth factors are enriched in all three cell types, i.e. Dlk1+SSChi, Dlk1+SSClo 
and OP9 cells. In addition, Dlk1+SSClo and OP9 cells also uniquely express 
more than 30 growth factors respectively, while 12 growth factors were highly 






Figure 4-2.  Venn diagram showing the common and distinct genes among 
the three lists of upregulated growth factors.   
Three lists of upregulated growth factors in the Dlk1+SSChi, Dlk1+SSCloand 
OP9 cells were used to generate Venn diagram. Each number in the diagram 













Upon thorough examination of the individual genes contained in each section 
of the Venn diagram, it appears that more than one region on the Venn 
diagram contains known hematopoietic growth factors, e.g. the angiopoietins, 
FGFs, WNTs, BMPs, IGFBPs and TGFs. Based on previous qPCR analysis  
showing  several HSC-supportive growth factors (i.e. Angptl3, Kitl/SCF, Tpo, 
IGF-2) are enriched in both Dlk1+SSChi and Dlk1+SSClo cells (Figure 3-4B), 
candidates lying in the common region between Dlk1+SSChi- and Dlk1+SSClo-
derived growth factors are of greatest  interest. Furthermore, the Dlk1+SSChi 
cell population are enriched for yolk sac visceral endoderm cells capable of 
supporting hematopoietic progenitors proliferation in co-culture (Figure 3-19). 
Hence, it would be important to investigate if other growth factors produced 
by this cell type might also be effective in supporting progenitor proliferation. 
We confined our genes of interest to four lists including 1) growth factors 
upregulated by Dlk1+SSChi, 2) growth factors upregulated by  both 
Dlk1+SSChi and Dlk1+SSClo, 3) growth factors upregulated by  both 
Dlk1+SSClo and OP9, and 4) growth factors upregulated by Dlk1+SSChi, 
Dlk1+SSClo and OP9. Genes contained in these four lists are shown in Table 4-
2, and their relative expression levels as indicated by both microarray and 
qPCR analysis can be seen in Figure 4-3 to 4-6. All genes short-listed were 
closely examined to reveal candidate growth factors that are important for 
hematopoiesis.  We conducted a thorough literature review to predict each 
growth factor’s potential to support hematopoiesis. Among the growth factors, 
those known to have hematopoiesis-related functions were summarized in 
Table 4-3.  Essential functions of other genes in the lists were also selectively 
summarized in Table 4-4-Table 4-7.  
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Table 4-3. Lists of upregulated growth factors expressed by Dlk1+SSChi, 
Dlk1+SSClo and OP9 cells. Growth factors highlighted in red were 
reported to support hematopoiesis in previous studies. 
32 Growth factors upregulated in Dlk1+SSChi, Dlk1+SSClo and OP9 
Eps8l2 Il15 Bmp4 Il18 
Lamb2 Neo1 Efemp2 Vegfb 
Lama5 Ccl9 Il33 Igfbp7 
Efnb1 Bmp1 Spp1 Thbs2 
Emp1 Pxn Igf2bp3 NRADD 
Pdgfa Cx3cl1 Grn Lamb1-1 
Mfge8 Vegfa Ccl7 Wnt5a 
Angpt2 Tgfbi Tmeff1 Cxcl12 
12 Growth factors upregulated in Dlk1+SSChi and Dlk1+SSClo 
Dlk1 Cmtm8 Igfbp5 Cmtm6 
Bmp7 Pdgfb Igfbp2 Mdk 
Apoe Igf2 Cxcl16 Igf2bp1 
20 Growth factors upregulated in Dlk1+SSClo and OP9 
Ptn Angptl2 Tgfb2 IL1RN 
Fstl1 Angpt1 Cmtm7 Inhba 
Csf1 Itga11 Wnt5b IL-6 
Tgfb3 Hgf Plat Itgb1 
Vegfc Ogn Cxcl1 Ctgf 
5 Growth factors upregulated in Dlk1+SSChi


















Figure 4-6.  qPCR validation for growth factors upregulated in  the Dlk1+SSChi population
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Table 4-4. List of previously identified hematopoiesis-related growth factors that are found to be upregulated in Dlk1+SSChi, Dlk1+SSClo 
and OP9 cells 








Essential for HSC survival, regulates angiogenesis and hematopoiesis 








Expressed by HSC niches in the bone marrow, regulates HSC number and 
function (Goldman et al., 2009); essential for yolk sac hematopoiesis and 




Il18 NP_032386 interleukin 18 
Stimulates T cells and macrophages to secret several other cytokines, 










Maintains long- and short- term hematopoietic stem cells by inhibiting 
canonical Wnt pathway and keeping hematopoietic stem cells in quiescent 








Prohibits primitive hematopoietic cells from entering into the cell cycle, 







Soluble human Dlk-1 inhibits differentiation of hematopoietic progenitors 












Symbol Product Name Main functions reported Cell population 
Ptn NP_032999 pleiotrophin Supports expansion of HSCs and ES cells (Soh et al., 2007; Himburg et al., 2010a) 
Dlk1+SSClo and 
OP9 
Angptl2 NP_036053 angiopoietin-like 2 




IL-6 NP_112445 interleukin 6 Together with interleukin 3 (IL-3), stimulates self-renewal divisions of HSCs in cultures (Bodine et al., 1989).   
Dlk1+SSClo and 
OP9 
Angptl3 NP_038941 angiopoietin-like 3 





Table 4-5. Reported functions of growth factors upregulated in Dlk1+SSChi, Dlk1+SSClo and OP9 
Symbol Product Name Main functions reported 




overexpression of the extracellular protein, Lamb2, in senescent prostate epithelial cells 
led to increased in vivo tumorigenicity through altheration of the microenvironment 
(Sprenger et al., 2008) 
Lama5 NP_001074640 laminin, alpha 5 epithelial Lama5 is required for murine lung development via promoting VEGF production and alveolar epithelial cell differentiation (Nguyen et al., 2005) 





Identified as an adhesion molecule (Jain et al., 2005); May have a role in neuronal 
differentiation and neurite outgrowth (Wulf and Suter, 1999) 
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Expressed by embryonic epicardium and myocardium, and serves as a mitogen during 
heart development (Kang et al., 2008) 
Mfge8 NP_001038954 
milk fat globule-
EGF factor 8 
protein 
Recognizes and presents apoptotic cells to phagocytes to undergo apoptosis (Hanayama et 
al., 2002; Borisenko et al., 2004) 
Angpt2 NP_031452 angiopoietin 2 Expressed by endothelial cells, and is a survival factor for endothelial cells during apoptosis (Kim et al., 2000) 
Il15 NP_032383 interleukin 15 
Serves as maturation factor in vitro and survival factor in vivo for natural kill cells (Carson 
et al., 1997; Puzanov et al., 1996), induces proliferation of mast cells (Tagaya et al., 1996), 
and inhibits apoptosis of T cells (Bulfone-Paus et al., 1997) 
Neo1 NP_001036217 Neogenin Stimulates myogenic differentiation (Kang et al., 2004) 
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Symbol Product Name Main functions reported 
Ccl9 NP_035468 
chemokine (C-C 
motif) ligand 9 
Controls recruitment of leukocytes to the pathologic sites during inflammatory responses 





Cleaves IGFBP3 to inhibit FGF-induced cell proliferation (Kim et al., 2011) 





Interact with CXCR1 progenitors derived from bone marrow, and is essential for smooth 





Serves as extracellular matrix protein and regulates adhesion and migration of endothelial 
cells (Nam et al., 2003) 
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matrix protein 2 
Supports maturation of smooth muscle cells along the aortic wall (Huang et al., 2010) 





Expressed by vascular endothelial cells, controls migration of endothelial cells during 
angiogenesis (Senger et al., 1996); Overexpression of Spp1 leads to smooth muscle cell 
proliferation (Gadeau et al., 1993) 
Igf2bp3 NP_076159 
insulin-like 
growth factor 2 
mRNA binding 
protein 3 




Symbol Product Name Main functions reported 
Grn NP_032201 Granulin Expressed by hematopoietic tissues (Bhandari et al., 1992); serves as a mitogenic factor for angiogenesis (Trinh et al., 1999) 
Ccl7 NP_038682 
chemokine (C-C 
motif) ligand 7 
Found in many tissues, may have the ability to respond to inflammation stimulation in situ 






like domains 1 
Expression is restricted to brain during development and has a role during neural 




growth factor B 
Supports neurogenesis in vivo (Sun et al., 2006); Has angiogenic activity and stimulates 






Has a putative role as a tumor suppressor or senescence factor (Swisshelm et al., 1995) 
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Functions as inhibitor of tumor growth and angiogenesis (Streit et al., 1999); Inhibits bone 







Homologous to death receptor, induces cell death via apoptosis in different cell lines 
(Wang et al., 2003) 
Lamb1-1 NP_032508 laminin B1 Regulates expression of alpha(7)-integrin, may be used to prevent muscle disease (Rooney et al., 2009) 
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Table 4-6. Reported functions of growth factors upregulated in Dlk1+SSChi and Dlk1+SSClo 
Symbol Product Name Main functions reported 
Bmp7 NP_031583 bone morphogenetic protein 7 
tumor growth of androgen-insensitive prostate carcinoma cells (Miyazaki et 
al., 2004); promotes proliferation of nephron progenitors (Blank et al., 2009)  
Apoe  NP_033826 apolipoprotein E 
deficiency in mice leads to impaired blood-nerve and blood-brain barriers 
(Nishitsuji et al., 2011) 
Cmtm8 NP_081570 
CKLF-like MARVEL 
transmembrane domain containing 8 
inhibits cell proliferation (Jin et al., 2005) and induces cell death by apoptosis 
(Jin et al., 2007) 
Pdgfb  NP_035187 
platelet derived growth factor, B 
polypeptide 
sustain tumorigenicity and self-renewal of glioma-derived cancer-initiating 
cells (Jiang et al., 2011) 
Igfbp5 NP_034648 
insulin-like growth factor binding 
protein 5 
inhibits proliferation and induces differentiation of murine osteosarcoma cells 
(Schneider et al., 2001) 
Igfbp2 NP_032368 
insulin-like growth factor binding 
protein 2 
induces expansion of epidermal progenitor cells through Hedgehog signaling 
pathway (Villani et al., 2010) 
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Symbol Product Name Main functions reported 
Cxcl16  NP_075647 chemokine (C-X-C motif) ligand 16 
stimulates cell proliferation and migration via PI3-kinase/Akt and Erk 
pathways (Hattermann et al., 2008) 
Cmtm6 NP_080312 
CKLF-like MARVEL 
transmembrane domain containing 6 
one of the eight chemokine-like factor superfamily members, function 




one of the heparin binding proteins, supports ex vivo expansion of ES cells 
(Yao et al., 2010) 
Igf2bp1  NP_034081 
insulin-like growth factor 2 mRNA 
binding protein 1 
knockdown of the RNA-binding protein can promote leukemia cell 
proliferation via IGF2-dependent mechanism (Liao et al., 2004); characterizes 
cord blood CD34+ stem cells and stabilizes c-myc expression in the pluripotent 







Table 4-7. Reported functions of growth factors upregulated in Dlk1+SSClo and OP9 cells 
Symbol Product Name Main functions reported 
IL1RN NP_080312 
CKLF-like MARVEL 
transmembrane domain containing 
6 
one of the eight chemokine-like factor superfamily members, function unknown 
(Han et al., 2003) 
Fstl1 NP_034081 
insulin-like growth factor 2 mRNA 
binding protein 1 
knockdown of the RNA-binding protein can promote leukemia cell proliferation 
via IGF2-dependent mechanism (Liao et al., 2004); characterizes cord blood 
CD34+ stem cells and stabilizes c-myc expression in the pluripotent stem cells 
(Ioannidis et al., 2005) 
Csf1 NP_001107001 
colony stimulating factor 1 
(macrophage) Essential for liver regeneration (Amemiya et al., 2011) 
Tgfb3 NP_033394 transforming growth factor, beta 3 
Plays a role in cell growth during platal fusion via phosphorylation of SMAD2 
(Cui et al., 2003) 
Vegfc NP_033532 
vascular endothelial growth factor 
C 
Expressed by macrophages, involved in antigen clearance and inflammation 
resolution (Kataru et al., 2009) 
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Symbol Product Name Main functions reported 
Tgfb2 NP_033393 transforming growth factor, beta 2 Inhibits growth of hematopoietic cells (Moses et al., 1990) 
Angpt1 NP_033770 angiopoietin 1 Functions as apoptosis survival factor  for endothelial cells (Kwak et al., 1999) 
Itga11 NP_795896 integrin alpha 11 
Applied as a marker to distinguish differentiation state of chondrocytes 
(Gouttenoire et al., 2010) 
Hgf NP_034557 hepatocyte growth factor 
Produced by bone marrow smooth muscle cells, and plays a role in 
mesenchymal stem cell differentiation (Li et al., 2011) 
Ogn NP_032786 osteoglycin 
A matrix molecules, has potential roles in regulating cell growth and 




transmembrane domain containing 
7 Expressed in regulatory T cells (Sugimoto et al., 2006) 
Wnt5b NP_033551 
wingless-related MMTV integration 
site 5B Expressed in several types of cancers (Saitoh and Katoh, 2002) 
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Symbol Product Name Main functions reported 
Plat NP_032898 plasminogen activator 
Supports outgrowth of CNS myelin following conditioned injury (Minor et al., 
2009) 
Cxcl1 NP_032202 chemokine (C-X-C motif) ligand 1 
Plays a role in neutrophil chemotaxis in adenoviral keratitis (Chintakuntlawar 
and Chodosh, 2009) 
IL1RN NP_001034790 interleukin 1 receptor antagonist 
Hematopoietic cells transduced with retrovirus of IL1RN results in 
reconstitution and prolonged expression of IL1RN (Boggs et al., 1995) 
Inhba NP_032406 inhibin beta-A 
Reduces proliferation of hematopoietic progenitors in bone marrow culture 
(Broxmeyer et al., 1988) 
Itgb1 NP_034708 
integrin beta 1 (fibronectin receptor 
beta) 
Stimulates tumorigenesis via inhibiting differentiation through Src/FAK 
signaling pathway (Meves et al., 2011) 
Ctgf NP_034347 connective tissue growth factor 
Functions to stimulate proliferation, growth and migration of vascular 





Table 4-8. Reported functions of growth factors upregulated in Dlk1+SSChi cells 
Symbol Product Name Main functions reported 
BMP6 NP_031582 bone morphogenetic protein 6 critical for iron homeostasis in the liver, the pancreas and the heart (Meynard et al., 2009) 
INHBC NP_034695 inhibin beta-C transient expression reduces proliferation and accelerate apoptosis of hepatocellular carcinoma cells (Vejda et al., 2003) 
Cmtm4 NP_705810 CKLF-like MARVEL transmembrane domain containing 4
one of the eight chemokine-like factor superfamily members, function unknown 
(Han et al., 2003) 
CCL25 NP_033164 chemokine (C-C motif) ligand 25 mediate lymphocyte-endothelium interaction (Svensson et al., 2002; Hosoe et al., 2004) 
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After a comprehensive literature review of candidates in the gene lists, we 
found Midkine (Mdk) to be a promising candidate for further studies. Mdk is a 
13 kDa heparin-binding molecule that has the function to enhance the 
outgrowth and survival of neuronal cells (Maeda et al., 1999). Mdk belongs to 
the same family of heparin-binding cytokines with Pleiotrophin (Ptn), a 
recently identified growth factor that supports expansion of HSCs and ES cells 
(Soh et al., 2007; Himburg et al., 2010a). The C-terminal domain, which 
contains most of the biological activities are conserved between Ptn and Mdk 
(Soh et al., 2007). Additionally, Mdk has been recently proved to promote 
self-renewal and proliferation of mouse embryonic stem cells (Yao et al., 
2010). Moreover, previous studies have shown that purified HSCs express 
receptor-type protein tyrosine phosphatase PTPζ on their surface, which is also 
one of the receptors for Mdk and Ptn. These properties led to our hypothesis 





4.2 Midkine is capable to support HSCs maintenance during in vitro 
culture 
To test whether Mdk is able to support HSCs, we carried out in vitro culture of 
purified HSCs in the presence of exogenous Mdk. First, we sorted HSCs 
(CD41-CD150+CD48+) from adult bone marrow (Figure 3-16), and then 
cultured them in a serum-containing media, supplemented with TPO, Kitl/SCF 
and FLT3 (TSF) for a period of 4 days. The TSF combination was chosen, 
because it was used in previous study to show that Ptn enhances proliferation 
of HSCs during in vitro culture (Himburg et al., 2010a). Different dosages of 
Mdk were added into culture to test the effective concentration range for Mdk 
to take effect. HSCs cultured in the presence of various amounts of Mdk 
supplement and freshly isolated HSCs (to serve as control) were injected into 
lethally irradiated mice recipients, and their peripheral blood was analyzed 4 
weeks post transplantation. In order to optimize the conditions in which Mdk 
functions most efficiently, the length of the culture period and the ratio of 
donor versus helper cells being injected were also tested (Table 4-9).  
The reconstitution results showed that as compared to freshly isolated HSCs, 
cultured HSCs with only the combination of TSF factors rapidly lost their 
repopulating capacity, while the addition of Mdk can significantly prevent 
such a loss (Figure 4-7). Three independent experiments all showed that the 
addition of Mdk enhances the maintenance of HSCs. As for the optimal 
dosage, results of Experiment 1 and 2 suggest that a higher dosage of 100ng/l 
of Mdk is more effective than 10ng/l of Mdk. However, in Experiment 3, 
10ng/l of Mdk was more efficient. The different scale of reconstitution levels 
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observed in Experiment 3 (60~80%) possibly caused the inaccurate 
quantification results, however, more accurate quantitative assay, such as 
limiting dilution still needs to be performed in order to reach a more 
comprehensive conclusion.  
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Table 4-9. Parameters of transplantation experiments for Mdk function testing 
Experiment No. 1 2 3 4 5 6 
Time post transplantation 5 weeks 4 weeks 4 weeks 5 weeks 4 weeks 11 weeks 
Culture period 4 days 4 days 4 days 7 days 7 days 4 days 
Donor/Helper 500/5x105 500/2x105 300/2x105 500/5x105 300/2x105 500/5x105
No. of mice 
Fresh HSC 5 5 5 5 5 5 
TSF 5 4 1 5 N.A. 4 
TSF+10ng/l Mdk 5 5 4 4 2 5 




Figure 4-7.  Competitive repopulation experiments show that Mdk can 
maintain the function of HSCs during in vitro culture.   
Experiment 1-3 represent three independent experiments. In each graph, each 
dot, square or triangle represents a recipient mouse. Freshly isolated CD45.2+ 
HSCs were injected as control, while HSCs cultured with different 
concentrations of Mdk or without Mdk were tested. Percentage of donor-
derived cells in recipients is shown as CD45.2+ cells within the total peripheral 
blood (PB) in the CD45.1 recipients. Bars indicate the median levels of 





In addition, reconstitution of individual lineages was also examined. HSCs 
maintained in the presence  of exogenous Mdk have higher capacity to give 
rise to all lineages of blood cells, including Thy-1.2+ marked T cells, B220+ 
marked B lymphoid cells, and CD11b+/Gr-1+ marked myeloid cells (Figure 4-
8). Among different lineages, no bias towards any particular lineage was 
observed in terms of the levels of reconstitution. Representative FACS 
analysis on the peripheral blood of recipients injected with HSCs being 
cultured with 100ng/l Mdk in Experiment 1 are also shown (Figure 4-9 – 4-
13). These results further confirmed that HSCs being maintained with TSF and 
Mdk are able to engraft the HSC niches in vivo, and they did retain their 


































































































































































Figure 4-8.  Analysis of reconstitution of peripheral blood for individual 
lineages demonstrates that Mdk-maintained HSCs possess multipotency. 
Amount of donor-derived cells of different lineages in peripheral blood (PB) 
of recipient mice is shown as percentage of CD45.2+ cells. Data was collected 
for Experiment 3 as shown in Figure 4-7. Each graph represents reconstitution 
for a specific lineage, such as Thy-1.2+ marked T cells, B220+ marked B 
lymphoid cells, and CD11b+/Gr-1+ marked myeloid cells. Each dot, square or 
triangle represents a recipient mouse. Bars indicate the median level of 





Figure 4-9.  Representative FACS plots showing the donor-derived 
CD45.1+ cells in the peripheral blood of recipients injected with cultured 




Figure 4-10.  Representative FACS plots showing the donor-derived Thy-
1.2+ cells in the peripheral blood of recipients injected with cultured HSCs 





Figure 4-11.  Representative FACS plots showing the donor-derived 
B220+ cells in the peripheral blood of recipients injected with cultured 





Figure 4-12.  Representative FACS plots showing the donor-derived Mac-
1+ cells in the peripheral blood of recipients injected with cultured HSCs 
treated with TSF with 100ng/l Mdk.   




Figure 4-13.  Representative FACS plots showing the donor-derived Gr-1+ 
cells in the peripheral blood of recipients injected with cultured HSCs 
treated with TSF with 100ng/l Mdk.   










In order to investigate if Mdk could help prolong the period for in vitro HSC 
maintenance, we tried to extend the culture period from 4 days to 7 days. 
However, we observed lower reconstitution levels even when HSCs were 
cultured with high concentration of 100ng/l Mdk (Figure 4-14). This result 
implies that Mdk is unable to support long period culture of HSCs in vitro. 
Finally, to determine whether the HSCs maintained in culture are long-term 
repopulating HSCs or short-term repopulating HSCs, we continued to examine 
the reconstitution levels of recipient mice at nearly 3 months post 
transplantation. We observed at 11 weeks post transplantation that HSCs 
cultured with Mdk reconstituted the peripheral blood of recipient mice to a 
level that is similar to that when fresh HSCs were used. However, HSCs being 
cultured only with TSF failed to reconstitute recipient mice (Figure 4-15). 
Taken together, Mdk is able to support maintenance of long-term repopulating 
















































































Figure 4-14.  Reconstitution of mice with injection of HSCs being cultured  
a long period of 7 days with or without addition of Mdk. 
Experiment 4 and 5 represent two independent experiments. In each graph, 
each dot, square or triangle represents a recipient mouse. Percentage of donor-
derived cells in recipients is shown as CD45.2+ cells within the total peripheral 
blood (PB) in the CD45.1 recipients. Bars indicate the median level of 
reconstitution. Data shown here represents short-term (4~5 weeks) 








































11 weeks post transplantation
 
Figure 4-15.  Reconstitution levels after longer period post 
transplantation. 
Peripheral blood (PB) in the CD45.1 recipients was analyzed at 11weeks post 
transplantation. In each graph, each dot, square or triangle represents a 
recipient mouse. Percentage of donor-derived cells in recipients is shown as 
CD45.2+ cells within the total peripheral blood (PB) in the CD45.1 recipients. 




CHAPTER FIVE: DISCUSSION AND FUTURE DIRECTION 
5.1 Function of yolk sac endoderm cells 
Previously, both endothelial and endoderm cells were proposed to be 
hematopoiesis-supportive stromal cells. For stromal cells of endothelial origin, 
both primary cells and cell lines were shown to support ex vivo expansion of 
hematopoietic progenitors and HSCs (Yoder et al., 1994; Li et al., 2003a).  
Yolk sac endoderm was suggested by previous studies to provide important 
signals for hematopoietic commitment, such as  Ihh (Indian hedgehog)  (Baron, 
2001; Dyer et al., 2001) and Bmp4 (bone morphogenetic protein 4) (Sadlon et 
al., 2004). However, yolk sac endoderm cells were shown to function as 
hematopoeisis-supportive stromal cells only in the forms of immortalized cell 
lines (Yoder et al., 1994). Our study, for the first time characterized primary 
yolk sac endoderm cells for their ability to support in vitro expansion of 
hematopoietic progenitors. Using Dlk1+SSChi as a sorting profile, we were 
able to isolate a relatively pure cell population representing the visceral 
endoderm cells within the yolk sac. Adult bone marrow-derived hematopoietic 
progenitors co-cultured with sorted Dlk1+SSChi cells increased 2 – 3 fold 
compared to progenitors cultured alone. This result correlates with previous in 
vivo data showing a dramatic expansion of hematopoietic progenitors within 
the yolk sac between E9.5 and E13.5 (Figure 1-3). Since the hematopoietic 
progenitors increase dramatically during this period, it suggests that the 
microenvironment/stromal cells at these stages are ideal for progenitor 
proliferation. Taken together, it suggests that yolk sac endoderm cells play an 
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important role in supporting the proliferation of progenitors during embryo 
development.   
The Dlk1+SSChi cells were also shown to highly express mRNAs for Tpo, Igf2, 
Angpl3 as well as Kitl/SCF, which are known HSC expansion factors. These 
four growth factors are sufficient to support a more than 20-fold ex vivo 
expansion of HSCs in a serum free culture medium (Zhang et al., 2008a). 
Thus, the Dlk1+SSChi cells were expected to support HSCs as well during ex 
vivo culture. However, in contrast, adult-repopulating HSCs diminished after 
being co-cultured with the sorted Dlk1+SSChi cells. One possible explanation 
for this result is that the production of those HSC-supportive factors by 
Dlk1+SSChi cells might not be sufficient to meet the requirements for HSC 
maintenance.   Nevertheless, the factors being produced still have an effect on 
progenitor expansion, which could possibly account for the increased number 
of hematopoietic colony-forming cells after co-culture. Considering the fact 
that the AGM is a major site for HSC generation at around E10.5~E13.5, 
circulating HSCs may only need temporary rather than long-term support 
when they meet the microenvironment in the yolk sac. On the other hand, 
current techniques used to culture the visceral endoderm cells might limit our 
ability to fully characterize their real functions in vivo.  In our culture system, 
the sorted Dlk1+SSChi cells, did not form an adherent monolayer in culture, 
rather they remained nonadherent (Zhang and Lodish, 2004a). Similarly, 
previously identified HSC-supportive stromal cells of fetal hepatic 
stem/progenitor identity were also found to remain as cell suspension during 
culture. Moreover, these fetal liver stromal cells only proved to support HSC 
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maintenance but not expansion, albeit a major event taking place in the E15.5 
fetal liver is the dramatic proliferation of HSCs. It is possible that cells of 
embryonic endoderm lineage may undergo apoptosis in the current culture 
system, and even the surviving cells might be compromised in their ability to 
produce HSC expansion factors. The difficulties  associated with culturing 
visceral endoderm cells have been experienced by many other research groups 
as well, and even for the maintenance yolk sac endoderm cell lines in culture, 
loss of expression of AFP was observed (Yoder et al., 1994). In order to fully 
demonstrate whether yolk sac endoderm cells have the function to support 
HSCs, the current culture conditions still needs further optimizations.  
Besides visceral endoderm cells, yolk sac endothelial cells were also shown to 
support HSC and hematopoietic progenitors maintenance/expansion in vitro. 
We still need to investigate whether these two types of yolk sac stromal cells 
function independently, or they need to interact with each other to further 
stimulate their ability to support hematopoiesis in vivo. 
5.2 Role of stromal cell-derived Dlk-1 
The Dlk-1 protein is a member of the epidermal growth factor (EGF)-like 
family (Laborda et al., 1993; Smas and Sul, 1993). Dlk-1 expression was 
detected in several embryonic hematopoietic tissues in previous studies.   First, 
it is expressed by a fetal liver stromal cell line AFT024, which is able to 
support “cobblestone area” formation (Moore et al., 1997b). More recently, 
Dlk-1 was also identified as a marker for primary HSC-supportive stromal 
cells of hepatic stem and progenitor cells identity. Dlk-1 was also found to be 
produce by stromal cells in the placental villi (Floridon et al., 2000).  In the 
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adult mice, Dlk-1 was detected in hematopoietic tissues, such as spleen and 
bone marrow as well. In our study, we demonstrated the application of Dlk-1 
as a marker for purification of yolk sac endoderm cells, and also showed that 
these cells are able to support expansion of hematopoietic progenitors in 
culture.  
Dlk-1 is homologous to members of the Notch/Delta/ Serrate family, which is 
involved in the regulation of hematopoiesis (Milner and Bigas, 1999) . Notch 
1, 2, 3 and 4 are the four Notch homologues identified (Ellisen et al., 1991; 
Weinmaster et al., 1991; Weinmaster et al., 1992; Lardelli et al., 1994; 
Uyttendaele et al., 1996). In addition, among the 12 Notch ligands, Delta and 
Serrate/Jagged family were detected in mammals. In mouse, Delta-like-1 and 
3 were identified (Bettenhausen et al., 1995; Dunwoodie et al., 1997), while 
Jagg-1 and 2 were identified in human and rat (Lindsell et al., 1995; Shawber 
et al., 1996; Luo et al., 1997; Li et al., 1998). Previous studies have shown 
that the Jagged/Serrate family is important in hematopoiesis (Li et al., 1998; 
Varnum-Finney et al., 1998; Carlesso et al., 1999; Walker et al., 1999; Milner 
et al., 1996; Bigas et al., 1998). However, the roles of the Delta family 
members in the hematopoiesis development have not been fully characterized. 
Dlk-1 exists either as a transmembrane or secreted protein (Smas et al., 1997). 
The soluble human Dlk-1 was recently demonstrated to inhibit differentiation 
of hematopoietic progenitors as well as stimulate their expansion ex vivo (Han 
et al., 2000). It is suggested that Dlk-1 functions through the activation of 
Notch signaling pathway, and modulation of apoptosis and cell cycle of 
hematopoietic cells. It remains unknown whether transmembrane/surface Dlk-
1 of mouse visceral endoderm cells possesses any biological function in 
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supporting hematopoietic cells. Investigating soluble mouse Dlk-1 in ex vivo 
culture of HSCs by blocking transmembrane/surface Dlk-1 of yolk sac 
endoderm stromal cells in co-culture may help to reveal the importance and 
mechanisms of Dlk-1 function. 
5.3 Mdk Signaling pathway 
Mdk is a heparin-binding growth factor containing 121 amino acids and is rich 
in cysteine (Tsutsui et al., 1991; Tomomura et al., 1990). Mdk expression is  
high during midgestation but low in the adult tissues (Kadomatsu et al., 1988). 
Mdk is also produced by multiple tumor cell types, and was shown to 
stimulate metastasis of tumors (Kadomatsu and Muramatsu, 2004; Kurtz et al., 
1995; Miyashiro et al., 1997; Garver et al., 1993; Tsutsui et al., 1993; 
Aridome et al., 1995). In addition, Mdk has been known to promote survival 
and growth of several other cell types, such as endothelial cells and neuronal 
cells (Muramatsu, 2002; Dai et al., 2006). More recently, Mdk was reported to 
support self-renewal and expansion of both mouse and human embryonic stem 
cells (ESCs) (Yao et al., 2010). In our study, Mdk was identified as a growth 
factor capable of supporting in vitro HSC maintenance when combined with 
other growth factors. 
Previous studies demonstrated that Mdk functions through the binding to its 
receptor, protein-tyrosine phosphatase ζ (PTPζ), and activating downstream 
signaling pathways. For example, Mdk- PTPζ promotes G1-S phase 
progression and inhibits cell apoptosis in osteoblasts, neurons and ESCs 
through the PI3K/Akt signaling pathway (Owada et al., 1999; Qi et al., 2001; 
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Stoica et al., 2002; Yao et al., 2010). Mdk also functions through stimulating 
tyrosine phosphorylation of STAT proteins, for example, STAT1 (Owada et 
al., 1999; Ratovitski et al., 1998) and STAT3. The Mdk-STAT3 signaling 
pathway plays an important role in adipogenesis by promoting mitotic 
expansion and differentiation of cells (Cernkovich et al., 2007). Studies on 
another heparin-binding protein, pleiotrophin (Ptn), further provided clues of 
possible mechanisms through which Mdk might have an effect on the 
hematopoietic cells. In a recent study, Ptn was reported to induce bone marrow 
stem/progenitor cells proliferation both in vitro and in vivo, and it is 
accomplished through its binding to the PTP-β/ζ receptor and activation of the 
PI3K/Akt and Notch signaling pathways.  Since Ptn and Mdk share the same 
receptors and were found to have similar functions in many cell types, we 
hypothesize that Mdk may regulate HSCs through the same mechanism as Ptn 
(Figure 5-1). Ptn expression was found to significantly increase in specific 
organs in the Mdk -/- mice as compared with Ptn expression in the wild type 
mice (Herradon et al., 2005). This provides evidence that Ptn is able to 
compensate the loss of Mdk. Future work involves determining whether Ptn 
and Mdk are functionally redundant in regulating HSCs. 
As bone marrow HSCs express receptors for Mdk on its surface, it is likely 
that Mdk regulates HSCs through direct binding to these receptors. However, 
as Mdk was also shown to promote angiogenesis (Choudhuri et al., 1997), and 
yolk sac endothelial cells serve as stromal cells for hematopoietic 
progenitor/stem cells expansion, Mdk may regulate hematopoiesis through 
affecting endothelial stromal cells in vivo.  
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As higher Mdk expression was detected within the Dlk1+SSClo cells than in 
the Dlk1+SSChi cells, further study is needed to determine the specific cell 
type that is producing Mdk within the yolk sac. It is possible that the high Mdk 
producing cells within the Dlk1+SSClo yolk sac cells are more potent than the 
Dlk1+SSChi endoderm cells in supporting hematopoiesis, especially for HSCs. 
Moreover, the microarray results showed similarity between the Dlk1+SSClo 
and OP9 cell, which is a well-documented hematopoiesis-supporting stromal 
cell type, it is implied that the potential stromal cells within the Dlk1+SSClo 




Figure 5-1. The possible mechanisms by which Mdk supports HSCs 
maintainance.  
The graph illustrates the possible mechanism of action of Mdk via binding to 
its receptor PTPζ and activating the PI3K/AKT pathway. (Adapted from Yao, 
Tan et al. 2010) 
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5.4 Challenges and future directions of ex vivo expansion of HSCs 
HSCs have been used to treat various types of blood disorders through bone 
marrow transplantation and  development of cord blood transplantation has 
widen HSCs therapeutic applications to treat patients who lack a 
histocompatible donor.  According to the 2009 World Marrow Donor 
Association Annual Reports, near 1.7 million new stem cell donors were 
registered and 78,000 units of cord blood were collected in the stem cell 
inventory in 2008. At the same time, the number of cord blood donations has 
been increasing over the years.  Due to the small number of HSCs contained in 
each unit of cord blood, its application for transplantation is limited mainly for 
pediatric patients.  Further improvements in the techniques for ex vivo 
expansion of HSCs are required to meet the clinical demands.   
It is important to identify novel factors to further enhance the proliferation and 
survival of HSCs as well as to prevent HSCs from differentiation in vitro. As 
more and more HSC-supportive factors are identified, optimization of various 
factor combinations needs to be worked out. Thus, better understanding of the 
signaling pathways through which the factors regulate HSCs and potential 
cross-talks between different regulatory pathways will be critical in the 
optimization of protocols for in vitro expansion of HSCs. Because the current 
state of the art techniques for in vitro HSCs are still far from efficient, it is also 
suggested that the three-dimensional microenvironment may be critical in 
improving the efficiency of culture. For example, modifications such as 
provision of integrin were shown to enhance the self-renewal of HSCs (Mei et 
al., 2010).  Other techniques such as immobilization of growth factors were 
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also shown to support HSCs during ex vivo culture (Han et al., 2000). 
Furthermore, novel bioreactors were proposed to mimic the stem cell niche 
and provide a solution for the complicated processes involving cell expansion 
and final selection (Chou et al., 2010; Astori et al., 2005; Liu et al., 2006). 
Automation of a more efficient culture system for HSCs expansion would 
ultimately reduce the cost of the treatment and benefit more patients. In this 
regard, this study provides better understanding of the HSC niche within the 
early stage mouse embryo, which will be essential in providing vital 
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